Z-score: Standardized Z‑score change in cognitive domain
DSM‑IV: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for dementia
3MSE: Modified Mini Mental State Exam
CDR: Clinical Dementia Rating
ADAS‑Cog: Alzheimer Disease Assessment Scale‑Cognitive Subscale
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
ADCS-CGIC: Alzheimer’s Disease Cooperative Study – Clinical Global Impression of Change
NPI: Neuropsychiatric Inventory
ADCS-ADL: Alzheimer’s Disease Cooperative Study – Activities of Daily Living
CDR-SOB: Clinical Dementia Rating – Sum of Boxes
CMAI: Cohen‑Mansfield Agitation Inventory
RMBPC: RMBPC rating scale for memory and behavioral problems in AD
MMSE: Mini-Mental State Examination
ADCS-ADLsev-abv: Alzheimer’s Disease Cooperative Study Activities of Daily Living Severity (above)
BEHAVE-AD-FW: BEHAVIORAL PATHOLOGY IN ALZHEIMER’S DISEASE – Frequency and Worsening
CIBIC-Plus: Clinician Interview-Based Impression of Change Plus
FAST-DS: Functional Assessment Staging Tool – Disability Scale
SIB: Severe Impairment Battery
NPI: Neuropsychiatric Inventory
CGIC: Clinical Global Impression of Change
BPRS: Brief Psychiatric Rating Scale
POMS FAT: POMS Fatigue Scale
POMS TEN: POMS Tension Scale
POMS ANG: POMS Anger Scale
POMS DEP: POMS Depression Scale
POMS VIG: POMS Vigor Scale
POMS CON: POMS Confusion Scale
GENISTEIN: Plasma Genistein Level
DIADZEIN: Plasma Diadzein Level
EQUOL: Plasma Equol Level
STROOP INT: Stroop Color Word Interference Time
MAZE TIME: Maze Completion Time
CAT FLUENCY: Category Fluency Words per Minute
LET FLUENCY: Letter Fluency Words per Minute
MMSE: Mini-Mental State Examination Score
BVRT: Benton Visual Retention Test Score
GPB: Grooved Pegboard Time
TMT B: Trail Making Test B Time
CF DEL REC: Complex Figure Delayed Recall Score
CF COPY: Complex Figure Copy Score
DEL REC: Logical Delayed Recall Score
FREE REC: Free Recall Total Score
GDS: Geriatric Depression Scale Score
SF-GDS: Short Form Geriatric Depression Scale Score
APOE: Apolipoprotein E Genotype (including APOE4 allele)
Death: All-cause mortality
CAS: Caregiver Activity Survey hours
Dependence Scale: Level of assistance needed
NPI: Neuropsychiatric Inventory total frequency×severity score
NPI Distress: Neuropsychiatric Inventory caregiver distress score
ADCS/ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory score
ADAS-cog: Alzheimer's Disease Assessment Scale Cognitive Subscale score
MMSE: Mini-Mental State Examination score
NAA: n-acetyl aspartate (hippocampal)
HV: Hippocampal Volume
ADAS-Cog: Alzheimer's Disease Assessment Scale-cognitive subscale
NPI: Neuropsychiatric Inventory
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
BSR: BSR test (short‑term memory)
CBIC+: CBIC+ assessment (global functioning)
SSPAL: SSPAL test (object‑location memory)
MMSE: Mini‑Mental State Examination
HOMA IR: Homeostasis Model Assessment of Insulin Resistance
HbA1c: Hemoglobin A1c
FPG: Fasting Plasma Glucose
Chol: Serum Cholesterol
ApoA: Apolipoprotein A
ApoB: Apolipoprotein B
CRP: C‑Reactive Protein
IL‑6: Interleukin‑6
TNF‑α: Tumor Necrosis Factor alpha
CD40: CD40
FDG‑PET: 18F‑Fluoro‑deoxy‑glucose Positron Emission Tomography (glucose metabolism)
CMRGlu: Global cerebral metabolic rate of glucose
Regional CMRglu: Regional cerebral metabolic rate of glucose (posterior cingulate, frontal, parietal, etc.)
Brain Volume Change: Percent brain volume change (MRI)
Normalized Brain Volume: Normalized brain volume (MRI)
APOE4: Apolipoprotein E epsilon 4 allele
UNMET: Unmet Need
EMBMEM: Embarrassment about Memory Problems
ISO: Isolation
RELSTR: Relationship Strain
DEP: Depression
ROLCAP: Role Captivity
PHYSHEALTH: Physical Health Strain
CARE_SUP: Caregiver Support Service Use
INF_HELP: Informal Helpers
SIB: Severe Impairment Battery
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
CIBIC-Plus: Clinician Interview-Based Impression of Change Plus
EQ-5D: EuroQol Five‑Dimension Questionnaire Proxy
CDR-SB: Clinical Dementia Rating – Sum of Boxes
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
MMSE: Mini‑Mental State Examination
DAD: Disability Assessment for Dementia
NPI: Neuropsychiatric Inventory
ACQLI: Alzheimer’s Caregiver Quality of Life Index
RUD: Resource Utilization in Dementia
HbA1c: Hemoglobin A1c
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
ALP: Alkaline Phosphatase
GGT: Gamma‑Glutamyl Transferase
LDH: Lactate Dehydrogenase
Creatinine: Serum Creatinine
BUN: Blood Urea Nitrogen
Cholesterol: Total Cholesterol
HDL: High Density Lipoprotein
LDL: Low Density Lipoprotein
Calcium: Serum Calcium
Magnesium: Serum Magnesium
Potassium: Serum Potassium
Phosphorus: Inorganic Phosphate
Sodium: Serum Sodium
CO2: Carbon Dioxide Content
Cl: Chloride
Total Protein: Serum Total Protein
Direct Bilirubin: Direct Bilirubin
Platelets: Platelet Count
RBC: Red Blood Cell Count
Hemoglobin: Hemoglobin
Hematocrit: Hematocrit
WBC: White Blood Cell Count
ANC: Absolute Neutrophil Count
Lymphocytes: Lymphocyte Count
Monocytes: Monocyte Count
Eosinophils: Eosinophil Count
Basophils: Basophil Count
MCV: Mean Corpuscular Volume
MCH: Mean Corpuscular Hemoglobin
MCHC: Mean Corpuscular Hemoglobin Concentration
RDW: Red Cell Distribution Width
Neutrophil Bands: Neutrophil Band Count
Segmented Neutrophils: Segmented Neutrophil Count
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
HR: Heart Rate
PR Interval: PR Interval
QRS Duration: QRS Duration
QT Interval: QT Uncorrected Interval
QTcB: QTc Bazett
QTcF: QTc Fridericia
RR Interval: RR Interval
Body Weight: Body Weight
AE: Adverse Event
SAE: Serious Adverse Event
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
EQ-5D Proxy Thermometer Score: Caregiver rating of overall health status on VAS
EQ-5D Proxy Utility Score: Caregiver rating of health status on multidimensional domains
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
MMSE: Mini-Mental State Examination
Hemoglobin: Hemoglobin concentration
Hematocrit: Hematocrit percentage
RUD Hours: Resource Utilization Data hours
Body Weight: Body weight measurement
ACQLI: Alzheimer’s Caregiver Quality of Life Index
APOE4: Apolipoprotein E epsilon 4 allele
Short Term Memory Assessment Score: Derived from ADAS-Cog Q1 & Q7
DAD: Disability Assessment for Dementia (activities of daily living)
NPI: Neuropsychiatric Inventory
NPI Psychosis Subscale: Delusions plus Hallucinations score
Adverse Event (AE): Untoward medical occurrence
Serious Adverse Event (SAE): Severe adverse event definition
Heart Rate: Beats per minute
Systolic Blood Pressure (SBP): Systolic BP
Diastolic Blood Pressure (DBP): Diastolic BP
HbA1c: Glycated hemoglobin
RBC: Red blood cell count
MCV: Mean corpuscular volume
MCH: Mean corpuscular hemoglobin
RDW: Red cell distribution width
WBC: White blood cell count
Lymphocytes: Lymphocyte count
Monocytes: Monocyte count
Eosinophils: Eosinophil count
Platelet Count: Platelet count
Segmented Neutrophil (SN): SN count
Total Neutrophil (TN): TN count
CIBIC-Plus-Plus: Clinician Interview-Based Impression of Change Plus-Plus
ADAS-COG: Alzheimer’s Disease Assessment Scale – Cognition Subscale
DAD: Disability Assessment for Dementia
Global composite: Weighted average of standardized neuropsychological test scores
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
NPI: Neuropsychiatric Inventory
Global rating of dementia severity: Global rating of dementia severity scale
ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale
HR: Heart Rate
SAE: Serious Adverse Event
AE: Adverse Event
DR-AE: Drug Related Adverse Event
PRM-AE: Permanent Discontinuation Adverse Event
HCT: Hematocrit
HB: Hemoglobin
LA: Lymphocyte Absolute
MA: Monocyte Absolute
PC: Platelet Count
RBC: Red Blood Cell Count
SNA: Segmented Neutrophil Absolute
TNA: Total Neutrophil Absolute
WBC: White Blood Cell Count
MMSE: Mini-Mental State Examination
CR: Creatinine
CK: Creatine Kinase
UR: Urea
GLU: Glucose
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
BW: Body Weight
PE: Peripheral Edema
CERAD-K Verbal Fluency: Verbal Fluency component of CERAD‑K
BNT: Boston Naming Test
MMS-K: Mini‑Mental State Examination Korean version
Word List Memory: Word List Memory subtest
Construction Praxis: Construction Praxis subtest
Word List Recall: Word List Recall subtest
Word List Recognition: Word List Recognition subtest
Construction Recall: Construction Recall subtest
Trail Making Test A: Trail Making Test Part A
Trail Making Test B: Trail Making Test Part B
NPI: Neuropsychiatric Inventory score
GDS-K: Geriatric Depression Scale Korean version
SER_BAPI_CONC: Serum bapineuzumab concentration
CL: Clearance
VSS: Steady state volume of distribution
MMSE: Mini‑Mental State Examination total score
PL_Aβ40: Plasma amyloid‑beta 40
MRT: Mean residence time
T½: Serum decay half‑life
HR: Heart rate (PCI ECG)
PR: PR interval (PCI ECG)
QRS: QRS interval (PCI ECG)
QTc: Corrected QT interval (PCI ECG)
HCT: Hematocrit (PCI laboratory)
HB: Hemoglobin (PCI laboratory)
WBC: White blood cell count (PCI laboratory)
NEUT: Neutrophil count (PCI laboratory)
PLT: Platelet count (PCI laboratory)
EOS: Eosinophil count (PCI laboratory)
Na: Sodium (PCI laboratory)
K: Potassium (PCI laboratory)
FBG: Fasting glucose (PCI laboratory)
PO4: Phosphorus (PCI laboratory)
Cr: Creatinine (PCI laboratory)
BUN: Blood urea nitrogen (PCI laboratory)
Ca: Calcium (PCI laboratory)
TP: Total protein (PCI laboratory)
Alb: Albumin (PCI laboratory)
UA: Uric acid (PCI laboratory)
ALT: Alanine aminotransferase (PCI laboratory)
AST: Aspartate aminotransferase (PCI laboratory)
TBIL: Total bilirubin (PCI laboratory)
ALP: Alkaline phosphatase (PCI laboratory)
GGT: Gamma‑glutamyl‑transpeptidase (PCI laboratory)
SBP: Supine systolic blood pressure (PCI vital signs)
DBP: Supine diastolic blood pressure (PCI vital signs)
PRATE: Pulse rate (PCI vital signs)
BT: Body temperature (PCI vital signs)
AUC_0_t: Area under the curve (0-t)
AUC_inf: Area under the curve (0-∞)
ANA: Serum anti‑bapineuzumab antibody concentration
ZBS: Zarit Short Burden Scale
MA: Medication Adherence Rating by Caregiver
RMC-NRS: Negative Reactions Scale of Revised Memory and Behavior Problem Checklist
RMC-FPB: Frequency of Problematic Behaviors of Revised Memory and Behavior Problem Checklist
BDI: Beck Depression Inventory
AL/NH: Assisted Living/Nursing Home Placement Rate
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
CNTB: Cognitive Neuroscience Test Battery
CSS: Cognitive Sequence Score
MMSE: Mini-Mental State Examination
DAD: Disability Assessment for Dementia
MCS: Modified Crichton Scale
CIBIC-plus-J: Clinician's Interview-Based Impression of Change plus Caregiver Input
BEHAVE-AD: BEHAVIOR AND PSYCHIATRIC SYMPTOMS of Alzheimer’s Disease
MENFIS: MENFIS
ADAS-J: Alzheimer's Disease Assessment Scale – Japan Cognitive Subscale
HbA1c: Hemoglobin A1c
CIBIC+: Clinician Interview-Based Impression of Change Plus
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
ALP: Alkaline Phosphatase
BUN: Blood Urea Nitrogen
Cr: Creatinine
GGT: Gamma Glutamyl Transferase
HDL: High Density Lipoprotein
LDL: Low Density Lipoprotein
LDH: Lactate Dehydrogenase
Mg: Magnesium
K: Potassium
P: Phosphorus
Na: Sodium
TP: Total Protein
TC: Total Cholesterol
TBIL: Total Bilirubin
TG: Triglycerides
CPK: Creatine Phosphokinase
CO2: Carbon Dioxide
Ca: Calcium
Cl: Chloride
RBC: Red Blood Cell Count
HGB: Hemoglobin
HCT: Hematocrit
WBC: White Blood Cell Count
NEUT: Neutrophils Count
LYMPH: Lymphocyte Count
MONO: Monocyte Count
EOS: Eosinophil Count
BASO: Basophil Count
MCV: Mean Corpuscular Volume
MCH: Mean Corpuscular Hemoglobin
MCHC: Mean Corpuscular Hemoglobin Concentration
RDW: Red Cell Distribution Width
PLT: Platelet Count
DAD: Disability Assessment for Dementia
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
MMSE: Mini-Mental State Examination
BW: Body Weight
EQ-5D Proxy: EuroQol 5-Dimensions Proxy
ACQLI: Acquaintance Caregiver Quality of Life Index
RUD: Resource Utilization in Dementia
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
HR: Heart Rate
PR: PR Interval
QRS: QRS Duration
QT: QT Interval
QTcB: QTc Bazett
QTcF: QTc Fridericia
RR: RR Interval
AE: Adverse Event
NPI: Neuropsychiatric Inventory
CGIC: Clinical Global Impression of Change
MMSE: Mini-Mental State Examination
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
NPI-10: Neuropsychiatric Inventory 10-item version
DISCONTINUATION ANY REASON: Number of participants who discontinued from the study due to any reason
DISCONTINUATION AE: Number of participants who discontinued from the study due to an adverse event
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
CDR-SOB: Clinical Dementia Rating Sum of Boxes
NPI: Neuropsychiatric Inventory
ADAS-cog 11: Alzheimer's Disease Assessment Scale Cognitive Subscale
MACCAT-CR Understanding: MacArthur Competence Assessment Tool for Clinical Research Understanding subscale
MACCAT-CR Appreciation: MacArthur Competence Assessment Tool for Clinical Research Appreciation subscale
MACCAT-CR Expression of a Choice: MacArthur Competence Assessment Tool for Clinical Research Expression of a Choice subscale
MACCAT-CR Reasoning: MacArthur Competence Assessment Tool for Clinical Research Reasoning subscale
WTC: Willingness to Consent (0=No, 1=Yes, 2=Unsure)
CPD: Consent Process Difficulty rating (1=Very Easy to 5=Very Hard)
Risky Behavior Checklist: Risky Behavior Checklist
CCSE: Revised Checklist for Caregiving Self‑Efficacy
MBRC CI: MBRC Caregiver Strain Index
ANS: General Anxiety Scale
TRDS: Test Result Distress Scale
DEP: Depression Scale
AE: Adverse Event
Aβ1-40 Ab GMT: Geometric Mean Titer of Aβ Peptide 1‑40 Specific Antibodies
Aβ1-40 Ab FC: GMT Fold Change of Aβ Peptide 1‑40 Specific Antibodies
FLCI: Functional Level Communication Index
ASHA FACS: American Speech‑Language‑Hearing Association Functional Assessment of Communication Skills
MMSE: Mini-Mental Status Exam
ADAS-cog: Alzheimer's Disease Assessment Scale-Cognitive
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
SST: Set‑Shifting Test
VT: Visual Tracking Test
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
UFOV: Useful Field of View
VPT: Visual Perception Test
VSCT: Visual‑Spatial Construction Test
DriveABLE: DriveABLE On‑Road Test
DS: Dementia Severity Scale
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
MMSE: Mini‑Mental State Examination
IADL: Instrumental Activities of Daily Living Scale
NPI: Neuropsychiatric Inventory
HCI: Hippocampal Connectivity Index
CBF: Cerebral Blood Flow Perfusion
HR: Heart Rate
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
Weight: Body Weight
MMSE: Mini-Mental State Examination
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
DAD: Disability Assessment for Dementia
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
BUN: Blood Urea Nitrogen
Creatinine: Creatinine
BUN/Creatinine ratio: BUN/Creatinine Ratio
CO2: Carbon Dioxide Content
Chloride: Chloride
Glucose: Glucose
HbA1c: Glycosylated Hemoglobin
Troponin I: Troponin I
CK: Creatine Kinase
LDH: Lactate Dehydrogenase
Magnesium: Magnesium
Potassium: Potassium
Sodium: Sodium
Total Bilirubin: Total Bilirubin
Direct Bilirubin: Direct Bilirubin
Gamma GT: Gamma Glutamyl Transferase
Urea: Urea
Albumin: Albumin
Cholesterol: Cholesterol
Triglycerides: Triglycerides
HDL: High-Density Lipoprotein
LDL: Low-Density Lipoprotein
TC: Total Cholesterol
Eosinophils: Eosinophils
Haematocrit: Haematocrit
Hemoglobin: Hemoglobin
Lymphocytes: Lymphocytes
MCH: Mean Corpuscular Haemoglobin
MCV: Mean Corpuscular Volume
Monocytes: Monocytes
Platelet Count: Platelets
RDW: Red Cell Distribution Width
RBC Count: Red Blood Cells
SN: Segmented Neutrophils
TN: Total Neutrophils
WBC: White Blood Cell Count
AE: Adverse Event
SAE: Serious Adverse Event
Oedema: Oedema
ADAS-cog: Alzheimer's Disease Assessment Scale-Cognitive
ADCS-IADL: Alzheimer's Disease Cooperative Study-Instrumental Activities of Daily Living
TMT-A: Trail Making Test part A
TMT-B: Trail Making Test part B
NPI-10: Neuropsychiatric Inventory 10-item
AE: Adverse Event Count
GI-AE: Gastrointestinal Adverse Events
SKIN-AE: Cutaneous Adverse Events
PSAT: Patient Satisfaction Score
MMSE: Mini Mental State Examination
MMSE: Mini-Mental State Examination
NPI: Neuropsychiatric Inventory
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
DAD: Disability Assessment for Dementia
CIBIC+: Clinician Interview-Based Impression of Change Plus
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
BUN/Cr: Blood Urea Nitrogen / Creatinine ratio
Chol: Cholesterol
CK: Creatine Kinase
Cr: Creatinine
DBIL: Direct Bilirubin
GGT: Gamma Glutamyl Transferase
GLU: Glucose
HDL: High Density Lipoprotein
LDL: Low Density Lipoprotein
K: Potassium
Tn1: Troponin 1
UR: Urea
HbA1c: Hemoglobin A1c
HR: Heart Rate
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
BW: Body Weight
mI:N-Acetylaspartate Ratio
mI:Creatine Ratio
mI:Choline Ratio
NAA:Creatine Ratio
NAA:Choline Ratio
Cr:Choline Ratio
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
MMSE: Mini-Mental State Examination
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
Mini-Zarit: Mini‑Zarit Caregiver Burden Inventory
TMT: Trail Making Test
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
SCB: Caregiver Burden Scale
MMSE: Mini-Mental State Examination
AE: Adverse Event
TOS: Therapeutic Outcome Scale
SIB: Severe Impairment Battery
QoL-AD: Quality of Life in Alzheimer’s Disease
GAtS: Goal Attainment Scaling
EQ-5D: EuroQol Five Dimensions
TEAV: Treatment-Emergent Adverse Value
NTB: Nine-Test Battery
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
NPI: Neuropsychiatric Inventory
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADRQL Total Score: Observer‑rated Quality of Life Instrument Total Score
DAD Total Score: Disability Assessment for Dementia Total Score
NPI-8 Total Score: Neuropsychiatric Inventory – 8 Item Total Score
CAS Total Time: Caregiver Activity Survey Total Time Spent
MMSE Total Score: Mini‑Mental State Examination Total Score
PVHVO: Percentage Active Voxels of Total Hippocampal Volume of Interest
WMS-R LM I: Wechsler Memory Scale Revised Logical Memory I
WMS-R LM II: Wechsler Memory Scale Revised Logical Memory II
WAIS: Wechsler Adult Intelligence Scale
TM-A: Trail Making Test Part A
TM-B: Trail Making Test Part B
WAIS Block Design: WAIS Block Design Subtest
MMSE: Mini-Mental State Examination
ADAS-Cog11: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale 11 item
NPI: Neuropsychiatric Inventory
ADAS-Cog14: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale 14 item
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
MMSE: Mini‑Mental State Examination
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
vMRI Hippocampal Volume: volumetric MRI measurement of left and right hippocampus
FDG-PET SUVR: Standard Uptake Value Ratio of 18F‑FDG normalized to Pons
AV-45 PET SUVR: Standard Uptake Value Ratio of amyloid tracer AV‑45 normalized to cerebellar gray matter
Total Tau CSF: Concentration of total tau in cerebrospinal fluid
P‑tau CSF: Concentration of phosphorylated tau in cerebrospinal fluid
Aβ1‑42 CSF: Concentration of amyloid beta 1‑42 in cerebrospinal fluid
Aβ1‑42 Plasma: Concentration of amyloid beta 1‑42 in plasma
Oral Clearance: Model‑estimated apparent oral clearance of LY450139
Apparent Volume Distribution: Model‑estimated apparent volume of distribution of LY450139
EQ‑5D Proxy: EuroQol five‑dimension quality of life proxy score
HRU: Healthcare Resource Utilization
MMSE: Mini‑Mental State Examination
4-IADL: 4‑item Instrumental Activities of Daily Living
Mini‑Zarit: Mini Zarit Caregiver Burden Interview
PT: Patient Tolerance to Rivastigmine Patch
CGIC: Clinician Global Impression of Change
TE4D: TE4D Psychometric Screening and Monitoring Test
ADCS-ADL19: Modified ADCS-ADL19 Functional Ability Scale
VAS: Visual Analog Scale for behavioral symptom burden
MMSE: Mini-Mental State Examination
NOSGER: NOSGER Comprehensive Behavior Scale
AP Δ %: Antipsychotic dose reduction percentage
CL: Clearance
CL/F: Apparent Systemic Clearance
Cavg,ss: Average Steady‑State Plasma Concentration
AUCτ: Area Under the Curve at Steady State
AE: Adverse Event
SAE: Serious Adverse Event
TEAE: Treatment‑Emergent Adverse Event
MRI BBSI: Magnetic Resonance Imaging Brain Boundary Shift Integral
ADAS-Cog/11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11-item score
CSF p-tau: Cerebrospinal Fluid Phosphorylated Tau
CSF tau: Cerebrospinal Fluid Total Tau
DAD: Disability Assessment for Dementia total score
PiB PET SUVr: Pittsburgh Compound B Positron Emission Tomography Standardized Uptake Value Ratio
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes total score
DS: Dependence Scale total score
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
DS: Dependence Scale
DAD: Disability Assessment for Dementia
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
PIB PET: Pittsburgh Compound B Positron Emission Tomography
CSF p-tau: Cerebrospinal Fluid phosphorylated tau
CSF tau: Cerebrospinal Fluid tau
MRI: Magnetic Resonance Imaging
ADAS-cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
CDR-SB: Clinical Dementia Rating Scale – Sum of Boxes
RBANS: Repeatable Battery for the Assessment of Neuropsychological Status
MMSE: Mini-Mental State Examination
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
APOE4: Apolipoprotein E epsilon 4 allele carriage
Eosinophils: Absolute Count
Hematocrit: Hematocrit Level
Lymphocytes: Lymphocyte Count
MCH: Mean Corpuscular Hemoglobin
Monocytes: Monocyte Count
Neutrophil Bands: Neutrophil Band Count
Platelet Count: Platelet Count
Segmented Neutrophils: Segmented Neutrophil Count
Total Neutrophils: Total Neutrophil Count
WBC: White Blood Cell Count
ALT: Alanine Aminotransferase
ALP: Alkaline Phosphatase
AST: Aspartate Aminotransferase
BUN/Creatinine Ratio: BUN/Creatinine Ratio
Calcium: Serum Calcium
Bicarbonate: Carbon Dioxide Content/Bicarbonate
Cholesterol: Total Cholesterol
CK: Creatine Kinase
Creatinine: Serum Creatinine
Direct Bilirubin: Direct Bilirubin
GGT: Gamma Glutamyl Transferase
Glucose: Fasting Glucose
HDL Cholesterol: High Density Lipoprotein Cholesterol
LDL Cholesterol: Low Density Lipoprotein Cholesterol
Magnesium: Serum Magnesium
Phosphorus: Inorganic Phosphate
Potassium: Serum Potassium
Sodium: Serum Sodium
Total Bilirubin: Total Bilirubin
Triglycerides: Serum Triglycerides
Urea/BUN: Urea/Blood Urea Nitrogen
Cavgss: Steady-State Average Concentration
Cmin-ss: Steady-State Trough Concentration
AUCτss: Area Under Curve Over Dosing Interval at Steady State
Brain Edema: Brain Edema
Hemorrhage: Hemorrhage
Encephalitis: Encephalitis
Cerebral/Meningeal Enhancement: Cerebral/Meningeal Enhancement
Parenchymal Hematoma: Parenchymal Hematoma
Subarachnoid Hemorrhage: Subarachnoid Hemorrhage
Subdural Hematoma: Subdural Hematoma
Cortical Infarct: Cortical Infarct
Subcortical Grey Matter Infarct: Subcortical Grey Matter Infarct
White Matter Infarct: White Matter Infarct
White Matter Hyperintensity: White Matter Hyperintensity
ADAS-cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
DAD: Disability Assessment for Dementia
PF-04360365-Ab: Anti-PF-04360365 Antibody
Plasma Aβ42: Plasma Amyloid‑Beta 1‑42 Concentration
AE: Adverse Event
SAE: Serious Adverse Event
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
NPI: Neuropsychiatric Inventory
CDR-Sb: Clinical Dementia Rating Sum of Boxes
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
MRI: Magnetic Resonance Imaging volumetry of hippocampus, posterior cingulate, and other regions
Aβ-42 Plasma: Plasma amyloid‑beta 1‑42
Aβ-40 Plasma: Plasma amyloid‑beta 1‑40
Tau CSF: Tau protein in cerebrospinal fluid
P-tau CSF: Phosphorylated tau in cerebrospinal fluid
Aβ-42 CSF: Amyloid‑beta 1‑42 in cerebrospinal fluid
Perfusion Imaging: NeuroGam parametric perfusion imaging
MMSE: Mini Mental State Examination
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
SDMT: Symbol Digit Modalities Test
SVF: Semantic Verbal Fluency Test
PVF: Phonetic Verbal Fluency Test
BNT: Boston Naming Test
RAVLT: Rey Auditory Verbal Learning Test
CSDD: Cornell Scale for Depression in Dementia
CBRS: Caregiver Interview-Based Rating Scale
VEM: Visual Episodic Memory Associate Learning Test
ADAS-Cog 11: Alzheimer's Disease Assessment Scale-Cognitive Subscale
WMS: Working Memory Scale
PMT: Psychomotor Task
ADAS-Cog 12: Alzheimer's Disease Assessment Scale-Cognitive Subscale
CGI-I: Clinical Global Impression – Improvement
VAAT: Visual Attention Assessment Test
EMT: Episodic Memory Test
BAPL: Beta-Amyloid Plaque Load score
KAPPA: Kappa coefficient for inter-reader agreement
SUVR: Standard Uptake Value Ratio of florbetaben signal
PET: Florbetaben positron emission tomography scan
IgM: Immunoglobulin M
IgG: Immunoglobulin G
NTB: Neuropsychological Test Battery
MMSE: Mini-Mental State Examination
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
DAD: Disability Assessment for Dementia
MRI: Magnetic Resonance Imaging
TEAE: Treatment-Emergent Adverse Event Count
Neurologic Exam Abnormalities: Neurological Examination Findings
Disturbing Behavior Scale: 24‑item scale measuring dementia patient disturbing behaviors
CES‑D: Center for Epidemiological Studies Depression Scale
QoL Dementia Scale: 32‑item quality of life questionnaire for dementia patients
CSF tau: Cerebrospinal Fluid Tau
CSF pTau181: Cerebrospinal Fluid Phospho‑Tau181
MMSE: Mini‑Mental State Examination
AB-Aβ: Anti‑Amyloid‑Beta Autoantibody
WBV: Whole Brain Volume
LHVP: Left Hippocampal Volume
RHVP: Right Hippocampal Volume
ADAS-ADL: Alzheimer’s Disease Assessment Scale‑Activities of Daily Living
CI: Cognitive Interview Score
PAβ1-40: Plasma Amyloid‑Beta 1‑40
PAβ1-42: Plasma Amyloid‑Beta 1‑42
CAβ1-40: Cerebrospinal Fluid Amyloid‑Beta 1‑40
CAβ1-42: Cerebrospinal Fluid Amyloid‑Beta 1‑42
FDG-PET: Fluorodeoxyglucose Positron Emission Tomography Glucose Metabolism
ADAS-cog: Alzheimer’s Disease Assessment Scale‑Cognitive
TMT A: Trail Making Test Part A
TMT B: Trail Making Test Part B
18FDG PET SUV_BSA2: 18F-Fluorodeoxyglucose PET Standardized Uptake Value normalized by Body Surface Area
Cube DT: Cube drawing test score
Clock DT: Clock drawing test score
Letter FLU: Letter fluency test score
Cat FLU: Categorical fluency test score
VFT: Verbal fluency test score
MMSE: Mini-Mental State Examination
CDR: Clinical Dementia Rating
GDS: Geriatric Depression Scale
FDG PET: 18F-fluorodeoxyglucose positron emission tomography
FCSRT: Free and Cued Selective Reminding Test
WAIS: Wechsler Adult Intelligence Scale
VBM MRI: MRI voxel-based morphometry measurement of cortical atrophy
BEHAV-AD: Behave‑AD CIBIC‑plus‑J subscale for psychotic symptoms
MENFIS: MENFIS Clinician's Interview-Based Impression of Change plus‑Japan subscale for mental function impairment
DAD: Disability Assessment for Dementia total score (%)
CIBIC PLUS-J: CIBIC plus‑Japanese version for overall change assessment
ADAS-J COG: ADAS‑Japanese cognitive subscale for memory, language, and behavior
WAIS-R Digit Span: Wechsler Adult Intelligence Scale – Revised Digit Span test
WAIS-R Digit Symbol Substitution: Wechsler Adult Intelligence Scale – Revised Digit Symbol Substitution test
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
QOL-AD: Quality of Life in Alzheimer’s Disease Questionnaire
FAS Verbal Fluency: FAS Letter Verbal Fluency test
Semantic Verbal Fluency (Animals): Animal Category Verbal Fluency test
NPI: Neuropsychiatric Inventory
ADAS-Cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
3MS: Modified Mini-Mental State Examination
TMT Part A: Trail Making Test Part A
TMT Part B: Trail Making Test Part B
Clock Drawing Test: Clock Drawing Test (Constructional ability)
SBP Threshold: Systolic blood pressure <90 mmHg or ±≥30 mmHg change
DBP Threshold: Diastolic blood pressure <50 mmHg or ±≥20 mmHg change
HR Threshold: Heart rate >120 bpm
PR Interval Threshold: ≥300 msec or ±≥25%/±≥50% change depending on baseline
QRS Interval Threshold: ≥200 msec or ±≥25%/±≥50% change depending on baseline
QT Interval Threshold: ≥500 msec
QTcF Interval Threshold: 450–<480, 480–<500, ≥500 msec or ±≥30–<60/≥60 msec change
Lab ULN/LLN Threshold: Values >X×ULN or <X×LLN
Urine Glucose/Ketone/Protein/Blood Qualitative Threshold: ≥1
Urine pH Threshold: >8 or <1.003 or >1.030
Urine Specific Gravity Threshold: <1.003 or >1.030
TOPS Mood Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Repetitiveness Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Aphasia Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Insight Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Domestic Activities Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Delusions Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Severity Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Remembering Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Telephoning Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Spatial Orientation Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Agitation Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Attention Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Caregiver Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Dressing Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Judgment Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Cognitive Activation Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Apathy Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Leisure Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Hygiene Symptom: Number of subjects Improved/Stabilized or Worsened
TOPS Temporal Orientation Symptom: Number of subjects Improved/Stabilized or Worsened
EuroQOL-5D Index: Health‑related quality of life index across five domains
EuroQOL-5D VAS: Visual analogue scale of overall health
MMSE Total Score: Mini‑Mental State Examination total score
HR QoL-AD Total Score: Health‑related Quality of Life – Alzheimer’s Disease total score
QoL-AD Total Score: Quality of Life – Alzheimer’s Disease total score
TEAE Count: Number of treatment emergent adverse events
CSDD: Cornell Scale for Depression in Dementia
NPI-10: Neuropsychiatric Inventory 10‑item subscale (excluding appetite and sleep)
NPI-4 A/A: Neuropsychiatric Inventory 4‑item agitation/aggression subscale
NPI Psychosis: Neuropsychiatric Inventory psychosis subscale
NPI Depression: Neuropsychiatric Inventory depression subscale
CGI‑S‑A/A: Clinical Global Impressions‑Severity for agitation/aggression
CGI‑S‑GF: Clinical Global Impressions‑Severity for global functioning
CMAI‑C: Cohen‑Mansfield Agitation Inventory – Community version
FrSBe: Frontal Systems Behavior Scale
ADAS‑Cog14: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale 14‑item
SUVR: Standardized Uptake Value Ratio
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living 19‑Item Total Score
CIBIC-plus: Clinician Interview‑Based Impression of Change Plus 7‑Point Global Rating
SIB: Severe Impairment Battery Total Score
NPI: Neuropsychiatric Inventory Total Score
Florbetapir-PET Visual Read: Florbetapir positron emission tomography visual read
Amyloid Plaque Density IHC: Amyloid plaque density assessed by quantitative immunohistochemistry
PET Scan Specificity Count: Number of subjects with negative florbetapir-PET scan determined by blinded readers
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory 19‑item total score
SIB: Severe Impairment Battery total score
CIBIC-plus: Clinician’s Interview‑Based Impression of Change‑Plus 7‑point global rating
NPI: Neuropsychiatric Inventory total score
CMAI: Cohen‑Mansfield Agitation Inventory Long Form total score
COWAT: Verbal Fluency Test
TBV: Total Brain Volume
HCV: Hippocampal Volume
MMSE: Mini-Mental State Examination
FCI: Financial Capacity Instrument
ADAS-Cog 14: 14‑item Alzheimer’s Disease Assessment Scale – Cognitive Subscale
CANTAB-SWM: Cambridge Automated Neuropsychological Test Battery – Spatial Working Memory
CANTAB-RTI: Cambridge Automated Neuropsychological Test Battery – Rapid Visual Information Processing
CANTAB-PAL: Cambridge Automated Neuropsychological Test Battery – Paired Associates Learning
DAD: Disability Assessment for Dementia
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
Behavioral Disturbance Scale: Caregiver‑rated behavioral disturbance score
CANTAB-PRM: Cambridge Automated Neuropsychological Test Battery – Pattern Recognition Memory
CGIC: Clinical Global Impression of Change
CMAI: Cohen‑Mansfield Agitation Inventory
NPI: Neuropsychiatric Inventory (agitation subscore)
NBRS-A: Neurobehavioral Rating Scale – Agitation
ADAS-cog+: Alzheimer's Disease Assessment Scale-Cognitive Subscale Plus
MRI: Brain Magnetic Resonance Imaging
Clinically Significant MRI: Classification of MRI findings deemed clinically significant
ADAS-cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
NPI: Neuropsychiatric Inventory
CGI-I: Clinical Global Impression – Improvement
C-SSRS: Columbia Suicide Severity Rating Scale
Orthostatic Hypotension: Drop of >10 mmHg diastolic or >20 mmHg systolic within 3 min of standing
Supine SBP: Supine systolic blood pressure
Supine DBP: Supine diastolic blood pressure
Standing SBP: Standing systolic blood pressure
Standing DBP: Standing diastolic blood pressure
PR interval: PR interval (electrocardiogram)
QRS duration: QRS complex duration
QT interval: QT interval
QTcB: QT interval corrected using Bazett's formula
QTcF: QT interval corrected using Fridericia's formula
WBC: White blood cell count
Hb: Hemoglobin
Hct: Hematocrit
RBC: Red blood cell count
Lymphocytes: Lymphocyte count
Neutrophils: Neutrophil count
Basophils: Basophil count
Eosinophils: Eosinophil count
Monocytes: Monocyte count
Bilirubin: Total bilirubin
AST: Aspartate aminotransferase
ALT: Alanine aminotransferase
Total protein: Total protein
Albumin: Albumin
Creatinine: Serum creatinine
Uric acid: Uric acid
Sodium: Sodium
Potassium: Potassium
Chloride: Chloride
Bicarbonate: Bicarbonate
Glucose: Glucose
HbA1c: Glycosylated hemoglobin
Ketones: Urine ketones
Urine protein: Urine protein
Urine blood: Urine blood/hemoglobin
Urine glucose: Urine glucose
Urine RBC: Urine red blood cells
Urine WBC: Urine white blood cells
Hyaline casts: Urine hyaline casts
T4: Tetraiodothyronine
T3: Triiodothyronine
TSH: Thyroid stimulating hormone
NAA/Cr: N-acetylaspartate to Creatine ratio
TEAEs: Treatment Emergent Adverse Events
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
HR: Heart Rate
Urine pH: Urine pH
Urine SG: Urine Specific Gravity
PR interval: PR Interval
QRS interval: QRS Interval
QTcF: QT Corrected using Fridericia's Formula
ECG: Electrocardiogram
TTau: Total Tau
PTau: Phosphorylated Tau
sAPPα: Soluble Amyloid Precursor Protein Alpha
sAPPβ: Soluble Amyloid Precursor Protein Beta
Aβ42: Amyloid Beta 1-42
Aβ40: Amyloid Beta 1-40
MMSE: Mini-Mental State Examination
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive
DAD: Disability Assessment for Dementia
MRI Findings: Structural MRI brain abnormalities
ADA: Anti‑Drug Antibody
Aβ(1-40): Amyloid beta 1‑40 in CSF
Aβ(1-42): Amyloid beta 1‑42 in CSF
Aβ(1-X): Amyloid beta unspecified variant in CSF
PIB SUVR: Standard Uptake Value Ratio of Pittsburgh Compound B
PF-04360365: Plasma concentration of investigational drug
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinician’s Global Impression of Change
NPI-12: Neuropsychiatric Inventory 12‑domain
ADCS-ADL-SIV: Alzheimer's Disease Cooperative Study Activities of Daily Living – Self‑Interview Version
SIB: Severe Impairment Battery
SUVR: Standardized Uptake Value Ratio of [18F]MK-3328 in cortical brain regions
PCG SUVR: Standardized Uptake Value Ratio of [18F]MK-3328 in posterior cingulate gyrus
RT: Residence Time of [18F]MK-3328 in organs
ED: Equivalent Dose (absorbed radiation dose) in organs
EffD: Effective Dose (Sieverts) for body
IgG: Immunoglobulin G
LLOQ: Lower Limit Of Quantification
NTB: Neuropsychological Test Battery composite z-score
WMS-VPA: Wechsler Memory Scale Visual-Paired Associates
WMS-VPA: Wechsler Memory Scale Verbal Paired Associates
RAVLT: Rey Auditory Verbal Learning Test
Digit Span: WMS Digit Span
CWAT: Controlled Word Association Test
CFT: Category Fluency Test
MMSE: Mini-Mental State Examination total score
Anti-Aβ IgM: Anti‑amyloid beta IgM titer geometric mean
Anti-Aβ IgG: Anti‑amyloid beta IgG titer geometric mean
MRI Brain Abnormalities Count: Number of participants with brain abnormalities in MRI
Neurological Exam Abnormalities Count: Number of participants with abnormalities in neurological examinations
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale total score
AE Severity Counts: Number of participants with mild, moderate, or severe adverse events
DAD: Disability Assessment for Dementia total score
IgG: Immunoglobulin G
LLOQ: Lower Limit Of Quantification
PR: PR Interval
QRS: QRS Interval
QTcF: QT Corrected Using Fridericia's Formula
AUC: Area Under the Plasma Concentration Time‑Curve
Hb: Hemoglobin
Hct: Hematocrit
RBC: Red Blood Cell Count
PLT: Platelet Count
WBC: White Blood Cell Count
LYM: Lymphocyte Count
NEUT: Neutrophil Count
BASO: Basophil Count
EOS: Eosinophil Count
MONO: Monocyte Count
BIL: Bilirubin
AST: Aspartate Aminotransferase
ALT: Alanine Aminotransferase
ALP: Alkaline Phosphatase
Cr: Creatinine
BUN: Blood Urea Nitrogen
GLU: Glucose
UA: Uric Acid
Na: Sodium
K: Potassium
Ca: Calcium
Cl: Chloride
HCO3: Bicarbonate
Alb: Albumin
TP: Total Protein
UA: Urine Analysis
SBP: Supine/Standing Systolic Blood Pressure
DBP: Diastolic Blood Pressure
HR: Pulse Rate
ADAS-Cog 11: Alzheimer's Disease Assessment Scale-Cognitive Subscale (11‑item)
DAD: Disability Assessment for Dementia (activities of daily living)
MMSE: Mini-Mental State Examination
NPI: Neuropsychiatric Inventory
AE: Adverse Events
WB: Wandering Behavior Count
DAD: Disability Assessment for Dementia
ADAS-Cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
NPI: Neuropsychiatric Inventory
MMSE: Mini-Mental State Examination
TEAE: Treatment‑Emergent Adverse Event
PET-Amyloid: Positron Emission Tomography Amyloid Imaging
SUVR: Standard Uptake Value Ratio
β‑Amyloid Histopathology: β‑amyloid presence/absence via Bielschowsky silver staining and immunohistochemistry
CERAD: Consortium to Establish a Registry for Alzheimer’s Disease neuropathologic criteria
WBA: Whole Brain Visual Assessment Classification
MMSE: Mini‑Mental State Examination
NPI: Neuropsychiatric Inventory
SPI: Sleep Problem Index
Hb: Hemoglobin
HCT: Hematocrit
RBC: Red Blood Cells
WBC: White Blood Cells
PLT: Platelets
NEUT: Neutrophils
LYMPH: Lymphocytes
EOS: Eosinophils
BASO: Basophils
MONO: Monocytes
TBIL: Total Bilirubin
AST: Aspartate Aminotransferase
ALT: Alanine Aminotransferase
ALKP: Alkaline Phosphatase
TP: Total Protein
ALB: Albumin
CREA: Creatinine
UREA: Urea
GLU: Glucose
UA: Uric Acid
Na: Sodium
K: Potassium
Cl: Chloride
Ca: Calcium
HCO3: Bicarbonate
URINE_RBC: Urine Red Blood Cells
URINE_WBC: Urine White Blood Cells
URINE_EPC: Urine Epithelial Cells
URINE_BACT: Urine Bacteria
URINE_GLU: Urine Glucose
URINE_KET: Urine Ketones
URINE_PROT: Urine Protein
PR: PR Interval
QRS: QRS Interval
QTcF: Fridericia Corrected QT Interval
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
HR: Heart Rate
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
ADAS-Cog14: Alzheimer's Disease Assessment Scale-Cognitive Subscale 14
ADAS-Cog12: Alzheimer's Disease Assessment Scale-Cognitive Subscale 12
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
NPI: Neuropsychiatric Inventory
MMSE: Mini-Mental State Examination
RUD-Lite: Resource Utilization in Dementia – Lite
EQ-5D: EuroQol Five Dimensions Questionnaire (proxy version)
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
vMRI: Volumetric MRI measurement of hippocampal volume
Aβ1-42: Amyloid-beta 1-42 peptide concentration in plasma
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
CHOICE RT: Choice Reaction Time
S-IADL: Seoul Instrumental Activities of Daily Living
DAD-K: Korean Assessment for Dementia Scale
SIMPLE RT: Simple Reaction Time
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
ADAS-cog: Alzheimer's Disease Assessment Scale – Cognitive subscale
AE: Adverse Event
ADAS: Alzheimer’s Disease Assessment Scale
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
MMSE: Mini-Mental State Examination
CIBIC-PLUS: Clinician Interview-Based Impression of Change Plus
GDS: Geriatric Depression Scale
IADL: Instrumental Activities of Daily Living
PSMS: Physical Self-Maintenance Scale
Global Deterioration Scale: Global Deterioration Scale
ADAS-NonCog: Alzheimer’s Disease Assessment Scale-Non Cognitive
hSA: Human Serum Albumin
ASL RelPerfRate: Regional cerebral perfusion measured by arterial spin labeling
ASL AvgRelPerfRate: Average regional cerebral perfusion measured by arterial spin labeling
CPAL Err: Number of errors in visual episodic learning task
CogDetRT: Simple reaction time measured by CogState detection task
CogIdRT: Choice reaction time measured by CogState identification task
CogIdAcc: Accuracy of choice reaction time measured by CogState identification task
RAVLT IR: Immediate recall score out of 105
RAVLT DR: Delayed recall score out of 30
RAVLT Rec: Recognition score out of 30
CIS: Caregiver Improvement Scale
QoL-AD: Quality of Life in Alzheimer’s Disease Questionnaire
ARICEPT Tolerance: Donepezil Tolerance
CGI-I: Clinical Global Impression – Improvement Scale
ARICEPT Dose: Donepezil Dose
CGIC: Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change
Digit Span: Wechsler Adult Intelligence Scale-Revised Digit Span
Abnormal Electrolytes: Percent of participants with abnormal electrolyte values
Death: Vital status measured by death
NPI Apathy Subscore: Neuropsychiatric Inventory apathy subscore
MMSE: Mini-Mental State Examination
Abnormal ECG: Abnormal electrocardiogram results
AES: Apathy Evaluation Scale
ADAS-cog 15: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale
BPRS: Brief Psychiatric Rating Scale
NPI: Neuropsychiatric Inventory
DBP: Double Blind Phase Duration
ADAS-Cog11: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 11
MMSE: Mini-Mental State Examination Total Score
vMRI HV: Hippocampal Volume by volumetric MRI
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Score
QoL-AD: Caregiver Total Quality of Life in Alzheimer’s Disease Score
NPI: Neuropsychiatric Inventory Total Score
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ABETA1-40: Plasma Amyloid-beta 1-40 Concentration
ABETA1-42: Plasma Amyloid-beta 1-42 Concentration
PET SUVR: Florbetapir F18 Standard Uptake Value Ratio
AE Count: Number of Participants with ≥1 Adverse Event
SAE Count: Number of Participants with ≥1 Serious Adverse Event
RUD-Lite: Caregiver Resource Utilization Hours
EQ-5D Index: US Population-Based Index Score
EQ-5D VAS: Visual Analogue Scale Score
ADAS-Cog14: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 14
LM-I: Logical Memory Immediate
LM-D: Logical Memory Delayed
FCSR: Free and Cued Selective Reminding Test (Free Recall)
COMMEM: Composite Memory Score
COMEXEC: Composite Executive Function Score
DIS: Disability Measure
CSDD: Cornell Scale for Depression in Dementia
REASONING: Latent variable derived from Letter and Word Inductive Reasoning and Matrix Reasoning
VERBAL MEMORY: Latent variable derived from Logical Memory, Delayed Logical Memory, Selective Reminding Task – Free Recall Total, Boston Naming Test
PHYSICAL PERFORMANCE TEST: 9‑item measure of physical function, range 0–34
VO2 MAX: Maximal oxygen consumption, ml/kg/min
SET MAINTENANCE AND SWITCHING: Latent variable derived from DKEFS Card Sort and Animal & Vegetable Category Fluency
SIMPLE ATTENTION: Latent variable derived from Digit Span Forward/Backward and Letter Numbers Sequencing
VISUOSPATIAL PROCESSING: Latent variable derived from Block Design, Stroop Color Reading, Digit Symbol Substitution, Trail Making Test A
LY2886721 AUC: Area Under the Curve of LY2886721
CSF Aβ1‑40: Cerebrospinal fluid amyloid‑beta 1‑40 concentration
Plasma Aβ1‑40: Plasma amyloid‑beta 1‑40 concentration
Adverse Events: Serious and Non‑Serious Adverse Events
DLZ: Delayed Recall Z-score
SUVR: Standardized Uptake Value Ratio on flutemetamol scan
PET-Amyloid: Amyloid PET imaging
Cognition Domain Z-Score: Domain‑specific cognitive z‑score
Global Cognition Z-Score: Global cognitive z‑score
Beta Weight: Latent growth curve coefficient relating amyloid to cognitive change
FAQ: Functional Assessment Questionnaire
CDR-GS: Clinical Dementia Rating Global Summary
p-tau: CSF Phosphorylated Tau
ADA: Anti-Drug Antibody
ADAS-Cog-13: Alzheimer's Disease Assessment Scale-Cognitive Subscale 13-item
ADAS-Cog-11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11-item
CDR: Clinical Dementia Rating
CDR-SOB: Clinical Dementia Rating Sum of Boxes
FCSRT: Free and Cued Selective Reminding Test
Time to Onset of Dementia: Time to Onset of Dementia
CANTAB Z-Composite Score: Cambridge Neuropsychological Test Automated Battery Z-Composite Score
HRV: Hippocampal Right Volume
HLV: Hippocampal Left Volume
MMSE: Mini-Mental State Examination
NPI: Neuropsychiatric Inventory
AUCτ,ss: Area Under the Concentration-Time Curve over one Dosing Interval at Steady State
Cnadir: Minimum Concentration
TEAE: Treatment-Emergent Adverse Event Count
PDQ: Perceived Deficits Questionnaire
PDQ-R: Perceived Deficits Questionnaire – Revised
VBSI: Ventricular Brain Volume Index
AD MACQ: Alzheimer’s Disease Medication Administration Choice Questionnaire
Anti-Aβ IgG Antibody Titer
Anti-Aβ IgM Antibody Titer
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
CDR-SOB: Clinical Dementia Rating Sum of Boxes
MMSE: Mini-Mental State Examination
NTB: Neuropsychological Test Battery
RUD-Lite: Resource Utilization in Dementia Lite
DS: Dependence Scale
FAQ: Functional Activities Questionnaire
NPI: Neuropsychiatric Inventory
NPI-D: Neuropsychiatric Inventory Distress
PET-F18: Florbetapir F18 Amyloid PET
BBSI: Brain Atrophy Index
HBSI: Hippocampal Brain Structure Index
Plasma Aβ x-40: Plasma Amyloid Beta 40 Concentration
Anti-Aβ IgG: Anti amyloid beta immunoglobulin G titer
AE Severity: Adverse Event Severity Count
NE Abnormality: Neurological Examination Abnormality Count
EM: Extensive Metabolizer
IM: Intermediate Metabolizer
CYP2D6: Cytochrome P450 2D6 enzyme activity classification
PK: Pharmacokinetics
ΔsCD40L: Change in soluble CD40 Ligand Levels
ORM-12741 PC: ORM‑12741 plasma trough concentration
NPI-Distress: Neuropsychiatric Inventory Distress Score
CDR-SpeedMem: Speed of Memory (Cognitive Drug Research)
CDR-QWMem: Quality of Working Memory (Cognitive Drug Research)
CDR-QMemory: Quality of Memory (Cognitive Drug Research)
CDR-PowerAtt: Power of Attention (Cognitive Drug Research)
CDR-ContAtt: Continuity of Attention (Cognitive Drug Research)
CDR-QEpiMem: Quality of Episodic Memory (Cognitive Drug Research)
NPI-Total: Neuropsychiatric Inventory Total Score
AE: Adverse Events
CSF-Abeta Oligomer: Cerebrospinal fluid amyloid‑beta oligomer concentration
HVLT Immediate: Hopkins Verbal Learning Test immediate recall score
HVLT Delayed: Hopkins Verbal Learning Test delayed recall score
HABC-Monitor: HABC‑Monitor total score
NPI Symptom Score: Neuropsychiatric Inventory symptom score
NPI Distress Score: Neuropsychiatric Inventory caregiver distress score
Discontinuation Rate: Medication discontinuation percentage
ADA: Anti‑Drug Antibody
NAb: Neutralizing Antibody
AB: Anti‑Body
PR Interval: PR Interval
QRS Interval: QRS Interval
QT Interval: QT Interval
QTcF: Corrected QT Interval (Fridericia)
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
Pulse Rate: Pulse Rate
Blood Pressure: Blood Pressure
Hb: Hemoglobin
Hct: Hematocrit
RBC Count: Red Blood Cell Count
RBC Morphology: Red Blood Cell Morphology
PLT Count: Platelet Count
WBC Count: White Blood Cell Count
Neutrophils: Neutrophil Count
Eosinophils: Eosinophil Count
Monocytes: Monocyte Count
Basophils: Basophil Count
Lymphocytes: Lymphocyte Count
BUN: Blood Urea Nitrogen
Creatinine: Serum Creatinine
Glucose: Serum Glucose
Ca: Serum Calcium
Na: Serum Sodium
K: Serum Potassium
Cl: Serum Chloride
HCO3: Serum Bicarbonate
AST: Aspartate Aminotransferase
ALT: Alanine Aminotransferase
Bil: Total Bilirubin
ALP: Alkaline Phosphatase
UA: Uric Acid
Alb: Serum Albumin
TP: Total Protein
Urine pH: Urine pH
Urine Glucose: Urine Glucose
Urine Protein: Urine Protein
Urine Blood: Urine Blood
Urine Ketones: Urine Ketones
Urine Nitrites: Urine Nitrites
Urine LE: Urine Leukocyte Esterase
Urine Microscopy: Urine Microscopy
Coag Panel: Coagulation Panel
Circulating IC: Circulating Immune Complex
Complement Activation: Complement Activation
MRI: Magnetic Resonance Imaging
DAD: Disability Assessment for Dementia
NPI: Neuropsychiatric Inventory
MMSE: Mini‑Mental State Examination
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
C-SSRS: Columbia Suicide Severity Rating Scale
FDG-PET SUVR: Standardized Uptake Value Ratio of FDG-PET for brain glucose utilization
HMW ADIPONECTIN: High molecular weight adiponectin concentration
EXECUTIVE FUNCTION SCALE: 9‑item executive function composite z‑score
ADAS-Cog 11: Alzheimer's Disease Assessment Scale – Cognitive Subscale total score
GLOBAL COGNITIVE Z- SCORE: composite z‑score from 19‑test neuropsychological battery
PSS: Perceived Stress Scale
PQoL: Perceived Quality of Life
BD: Behavior Disturbance
ADCS-CGIC: Alzheimer’s disease Cooperative Study-Clinical Global Impression of Change
ADAS-Cog: Alzheimer’s Disease Assessment Scale Cognitive Subscale
NPI: Neuropsychiatric Inventory
NPI-D: Caregiver Distress Scale
ADCS-ADL: Alzheimer’s Disease Cooperative Study-Activities of Daily Living
MMSE: Mini-Mental State Examination
FDG-PET: 18F-Fluorodeoxyglucose Positron Emission Tomography
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
MMSE: Mini‑Mental State Examination
TMT-A: Trail Making Test – Part A
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
AE Count: Number of Adverse Events
Abeta42-P: Plasma Amyloid Beta 1-42
Abeta40-P: Plasma Amyloid Beta 1-40
Abeta42-C: CSF Amyloid Beta 1-42
Abeta40-C: CSF Amyloid Beta 1-40
Abeta42/40-C: CSF Amyloid Beta 1-42/1-40 Ratio
tau-C: CSF Total Tau
p-tau-C: CSF Phosphorylated Tau
ALB-Q: CSF Albumin Quotient
Lp-PLA2: Lipoprotein-associated Phospholipase A2 Activity
Lp-PLA2 Inhib: Lipoprotein-associated Phospholipase A2 Inhibition %
CogState Overall: CogState Battery Overall Composite Score
CogState WM/EF: CogState Working Memory/Executive Function Composite Score
CogState Attention: CogState Battery Attention Composite Score
TRAILS_B_ERRORS: Trails B mean sum of errors
TRAILS_B_TIME: Trails B mean completion time (seconds)
RBANS_LIST_LEARNING: RBANS List Learning score
RBANS_STORY_MEMORY: RBANS Story Memory score
RBANS_FIGURE_COPY: RBANS Figure Copy score
RBANS_LINE_ORIENTATION: RBANS Line Orientation score
RBANS_SEMANTIC_FLUENCY: RBANS Semantic Fluency score
RBANS_LIST_RECALL: RBANS List Recall score
RBANS_LIST_RECOGNITION: RBANS List Recognition score
RBANS_STORY_RECALL: RBANS Story Recall score
RBANS_FIGURE_RECALL: RBANS Figure Recall score
DIGIT_SPAN_FORWARD: Digit Span Forward score
DIGIT_SPAN_BACKWARD: Digit Span Backward score
BOSTON_NAMING: Boston Naming score
SMT_RATIO: Sniff Magnitude Test ratio
NPI: Neuropsychiatric Inventory
BPRS: Brief Psychiatric Rating Scale
CGI: Clinical Global Impression
AIMS: Abnormal Involuntary Movement Scale
Barnes Akathisia Rating Scale: Barnes Akathisia Rating Scale
SAS: Simpson-Angus Scale
MMSE: Mini-Mental State Examination
AE: Adverse Event
SAE: Serious Adverse Event
Bradycardia: Heart rate ≤50 bpm and ≤15 bpm decrease from baseline
Supraventricular Premature Beat: ≥2 per 10 seconds and any increase from baseline
1st Degree AV Block: PR ≥0.20 s and increase ≥0.05 s from baseline
Intraventricular Conduction Block: QRS ≥0.12 s and increase ≥0.02 s from baseline
QTcB: QTcB ≥450 ms and ≥10% increase from baseline
QTcN: QTcN ≥450 ms and ≥10% increase from baseline
Hematocrit Shift: 3 point shift from baseline
SBP Increase: ≥180 mmHg and ≥20 mmHg increase from baseline
DBP Increase: ≥105 mmHg and ≥15 mmHg increase from baseline
HR Increase: ≥120 bpm and ≥15 bpm increase from baseline
Weight Increase: ≥7% increase from baseline
CIBIC-plus: Clinician's Interview-Based Impression of Change Plus
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
ADAS-cog: Alzheimer's Disease Assessment Scale Cognitive Subscale
NPI: Neuropsychiatric Inventory
FA: Fractional Anisotropy
MD: Mean Diffusivity
SUVR: Standardized Uptake Value Ratio
CDR: Clinical Dementia Rating
Hippocampal Volume (LEAP): Hippocampal Volumetry via LEAP
BBSI: Baseline Brain Scan Index
VBSI: Voxel-based Structural Index
Functional Connectivity: Resting-state Functional Connectivity
ADAS-Cog14: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 14
MMSE: Mini-Mental State Examination
Apathy Scale: Apathy Scale by Starsktein et al
CSF-Abeta40: Cerebrospinal fluid amyloid‑beta 40 concentration
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Score
MRI Whole Brain Volume: Rate of whole brain volume change
ADAS-Cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
CGI-C: Clinical Global Impressions – Change
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impression of Change
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
NPI: Neuropsychiatric Inventory
QOL-AD: Quality of Life in Alzheimer’s Disease
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive
IADCQ: Informant’s Assessment of Deterioration in Cognition Questionnaire
AE: Adverse Event
ADCS-ADL Change: Alzheimer's Disease Cooperative Study Activities of Daily Living Score Change
ADAS-Cog Change: Alzheimer's Disease Assessment Scale-Cognitive Subscale Score Change
Plasma Aβ40: Plasma amyloid beta 1-40 concentration
Plasma Aβ42: Plasma amyloid beta 1-42 concentration
CSF Aβ40: Cerebrospinal fluid amyloid beta 1-40 concentration
CSF Aβ42: Cerebrospinal fluid amyloid beta 1-42 concentration
CSF tau: Cerebrospinal fluid total tau concentration
CSF p-tau181: Cerebrospinal fluid phosphorylated tau 181 concentration
NTB Z-score: Neurological Test Battery Z-score
ADAS-Cog11: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 11-item score
ADAS-Cog14: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 14-item score
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes score
MMSE: Mini-Mental State Examination score
Dose mSv/MBq: Radiation dose values in millisieverts per megabecquerel
SUVR: Standardized Uptake Value Ratio
Image Quality Rating: Visual image quality rating on a 5‑point scale
SUVR: Standardized Uptake Value ratio
SUVR: Standardized Uptake Value ratio
PET Amyloid 5-point Scale: 0-4 scale for amyloid deposition
Amyloid Positive/Negative: binary classification from PET
Percent Agreement 30-40min vs 50-60min PET: percentage of majority read concordance
PET: Positron Emission Tomography Scan Read
Sens: Sensitivity – percent of true positives detected by PET
Spec: Specificity – percent of true negatives detected by PET
Agree: Read Agreement – percent of individual scans agreeing with majority
Amyloid Status: Amyloid positive/negative classification
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinician Global Impression of Change
mADCS-CGIC: Modified ADCS Clinician Global Impression of Change
PGI-C: Patient Global Impression of Change
NPI: Neuropsychiatric Inventory
NPI4D: NPI Distress Score (sum of Agitation/Aggression, Irritability/Lability, Disinhibition, Aberrant Motor Behavior)
NPI4A: NPI Distress Score (Agitation/Aggression, Irritability/Lability, Anxiety, Aberrant Motor Behavior)
NPI-CDS: NPI Caregiver Distress Score
MMSE: Mini‑Mental State Examination
CSI: Caregiver Strain Index
QoL-AD: Quality of Life in Alzheimer’s Disease
CSDD: Cornell Scale for Depression in Dementia
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
TEAE: Treatment‑Emergent Adverse Event
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
MMSE: Mini-Mental State Examination
AE: Adverse Events
Discontinuation Rate: Discontinuation rate due to treatment switching or intolerance
Titration Success: Proportion of patients successfully titrated to rivastigmine patch
SUVR: Standard Uptake Value Ratio
SUV: Standard Uptake Value
ADAS-Cog: Alzheimer's Disease Assessment Scale – Cognitive subscale
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
Device SAE: Serious device‑related adverse events
Procedure SAE: Serious procedure‑related adverse events
Therapy SAE: Serious therapy‑related adverse events
J-CGIC: Japanese Clinician’s Global Impression of Change
MMSE: Mini‑Mental State Examination
TR: Treatment Retention Rate
ADAS-J: Alzheimer’s Disease Assessment Scale – Japan Cognitive Subscale
AE-D: Adverse Event Leading to Discontinuation
ADAScog: Alzheimer's Disease Assessment Scale Cognitive Subscale
PAL memory: Paired Associates Learning memory score
PAL total trial adj: Paired Associates Learning total trial adjusted score
TEAE: Treatment Emergent Adverse Event Count
OrgDose: Organ dose in millisieverts per megabecquerel
NAA: N-acetylaspartate neuronal viability marker measured by 1H MRS
Glutamate: Glutamate metabolite measured by 1H MRS
NPI: Neuropsychiatric Inventory total score
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
ADAScog: Alzheimer's Disease Assessment Scale Cognitive Subscale
FDG PET: Cerebral glucose metabolism measured by fluorodeoxyglucose positron emission tomography
Diagnostic Confidence %: Physician diagnostic confidence percentage change
Fortinsky Caregiver Self‑Efficacy: Total score on the Fortinsky family caregivers’ self‑efficacy for managing dementia scale
Management Change %: Proportion of patients changing management in major diagnostic tests
Management Change %: Proportion of patients changing management in Alzheimer’s/cognition medication
Management Change %: Proportion of patients changing management in neuropsychological tests
Management Change %: Proportion of patients changing management in physician follow‑up
Management Change %: Proportion of patients changing management in advice and counseling
ADAS‑Cog 11 Change: Alzheimer’s Disease Assessment Scale – Cognitive Subscale score change
PR: PR interval
QTcF: QTcF interval
QRS: QRS complex
NPI: Neuropsychiatric Inventory total score
ADAS-cog13: 13‑item Alzheimer’s Disease Assessment Scale‑Cognitive Subscale
C-CASA: Columbia Classification Algorithm of Suicide Assessment
TEAE: Treatment‑Emergent Adverse Event
Hb: Hemoglobin
Hct: Hematocrit
RBC: Red Blood Cell Count
PLT: Platelet Count
WBC: White Blood Cell Count
Neu: Neutrophils
Eos: Eosinophils
Mono: Monocytes
Baso: Basophils
Lymph: Lymphocytes
BUN: Blood Urea Nitrogen
Cr: Creatinine
Gluc: Glucose
Ca: Calcium
Na: Sodium
K: Potassium
Cl: Chloride
HCO3: Total Bicarbonate
AST: Aspartate Aminotransferase
ALT: Alanine Aminotransferase
Bilirubin: Bilirubin
ALP: Alkaline Phosphatase
UA: Uric Acid
Alb: Albumin
TP: Total Protein
Urine pH: Urine pH
Urine Glucose: Urine Glucose
Urine Protein/Albumin: Urine Protein/Albumin
Urine Hemoglobin/Blood: Urine Hemoglobin/Blood
Urine Ketones/Acetone: Urine Ketones/Acetone
Urine Nitrites: Urine Nitrites
Urine Leukocyte Esterase: Urine Leukocyte Esterase
Microscopy: Urine Microscopy
Urine Drug Screen: Urine Drug Screen
Thyroid Panel: Thyroid Panel
Vit B12: Vitamin B12
MMA: Methylmalonic Acid
Folate: Folate
HbA1: Hemoglobin A1
BP: Blood Pressure
Pulse Rate: Pulse Rate
ARIA-E: Alzheimer’s Related Imaging Abnormalities – Edema
ARIA-H: Alzheimer’s Related Imaging Abnormalities – Hemorrhage/Siderosis
MBs: Cerebral micro-hemorrhages detected on MRI
ATA: Anti-drug Antibody against crenezumab
CTCAE v4.0: Adverse Event Severity Grading Scale
Aβ1-42: Amyloid-beta 1-42 in cerebrospinal fluid
CLU: Clusterin in cerebrospinal fluid
FCSRT: Free and Cued Selective Reminding Test delayed free recall
AE: Adverse Events
p-tau181: Phosphorylated tau 181 in cerebrospinal fluid
AQS: Attention Questionnaire Score
MMSC: Mini-Mental Status Cognitive Questionnaire
BI: Caregiver Burden Index
BA1-40 Serum: Beta amyloid1-40 serum level
BA1-42 Serum: Beta amyloid1-42 serum level
BA42/BA40 Ratio: Ratio of Beta Amyloid 42 to Beta Amyloid 40
CDR: Clinical Dementia Rating Scale
NPI: Neuropsychiatric Inventory
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
Amyloid PET SUVr: Amyloid burden measured by standardized uptake value ratio on 18F‑AV‑45 PET
MMSE: Mini‑Mental State Examination
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
SAE: Serious Adverse Event
Cmax: Maximum Concentration
AUC: Area Under the Curve
CCS-3D: Cognitive composite Z score (episodic memory, executive function, attention/processing speed)
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
ADAS-Cog11: Alzheimer's Disease Assessment Scale – Cognitive Subscale 11
AE Discontinuation: Number of participants discontinuing study drug due to an adverse event
AE Count: Number of participants experiencing an adverse event
MOCA: Montreal Cognitive Assessment
AUC: Area Under the Concentration versus Time Curve
EQ-5D: EuroQol Five-Dimension Health Status
FAQ: Functional Activities Questionnaire
FLORBETAPIR PET: Florbetapir Positron Emission Tomography Imaging of Amyloid
HCRU: Healthcare Resource Utilization
iADRS: Integrated Alzheimer's Disease Rating Scale
LD:???
MMSE: Mini-Mental State Examination
PET SUVr: Standardized Uptake Value Ratio
Aβ1-42 CSF: Amyloid-beta 1-42 in Cerebrospinal Fluid
Aβ1-42 Plasma: Amyloid-beta 1-42 in Plasma
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11 Items
ADAS-Cog14: Alzheimer's Disease Assessment Scale-Cognitive Subscale 14 Items
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
NPI: Neuropsychiatric Inventory
QoL-AD: Quality of Life in Alzheimer's Disease
vMRI: Volumetric MRI Measurement of Hippocampal Atrophy
AVQA: Amyvid VisQ Accuracy
QSIA: Qualitative Scan Interpretation Accuracy
FK: Fleiss' Kappa statistic
ADAS-cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
MMSE: Mini-Mental State Examination
NPI-12: Neuropsychiatric Inventory-12
NPI-10: Neuropsychiatric Inventory-10
CBI: Caregiver Burden Interview
EQ-5D: EuroQol 5‑Dimensional Health Questionnaire
EQ-5D VAS: EuroQol 5‑Dimensional Visual Analogue Scale
MMSE: Mini Mental State Examination
ADAS-cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
ADCS-ADL23: Alzheimer’s Disease Cooperative Study – Activities of Daily Living Inventory (23‑item)
ADCS-CGIC: Alzheimer’s Disease Cooperative Study – Clinical Global Impression of Change
NPI: Neuropsychiatric Inventory
NPI Anxiety Item: Neuropsychiatric Inventory Anxiety Item
NPI Single Item: Neuropsychiatric Inventory Single Item Score
SUVR 18F‑AV‑1451: Standardized Uptake Value Ratio of 18F‑AV‑1451
SUVR Flortaucipir: Standardized Uptake Value Ratio of flortaucipir
AE: Adverse Event
SAE: Serious Adverse Event
FCSRT Immediate Recall: Free and Cued Selective Reminding Test Immediate Recall
FCSRT Delayed Recall: Free and Cued Selective Reminding Test Delayed Recall
FCSRT Cueing Index: Free and Cued Selective Reminding Test Cueing Index
RBANS Immediate Memory: Repeatable Battery for the Assessment of Neuropsychological Status Immediate Memory
RBANS Visuospatial/Constructional: Repeatable Battery for the Assessment of Neuropsychological Status Visuospatial/Constructional
RBANS Language: Repeatable Battery for the Assessment of Neuropsychological Status Language
RBANS Attention: Repeatable Battery for the Assessment of Neuropsychological Status Attention
RBANS Delayed Memory: Repeatable Battery for the Assessment of Neuropsychological Status Delayed Memory
RBANS Total Scale Index: Repeatable Battery for the Assessment of Neuropsychological Status Total Scale Index
Time to Progression: Time to progression from preclinical AD to MCI or dementia
FDG-PET Regional CMRgl: Fluorodeoxyglucose Positron Emission Tomography Regional Cerebral Metabolic Rate of Glucose
FDG-PET SUVR: Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Value Ratio
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
CDR Global: Clinical Dementia Rating Global Score
ARIA-E: Amyloid-related Imaging Abnormality Edema/Effusion
ARIA-H: Amyloid-related Imaging Abnormality Hemosiderin Deposition
MRI Macrohemorrhage: Magnetic Resonance Imaging Detection of Cerebral Macrohemorrhage
ADA: Anti-Drug Antibody against crenezumab
Aβ1-40 Plasma: Amyloid-beta 1-40 in Plasma
Aβ1-42 Plasma: Amyloid-beta 1-42 in Plasma
Aβ1-42/1-40 Plasma Ratio: Amyloid-beta 1-42 to 1-40 Ratio in Plasma
CSF Aβ1-40: Amyloid-beta 1-40 in Cerebrospinal Fluid
CSF Aβ1-42: Amyloid-beta 1-42 in Cerebrospinal Fluid
CSF Aβ1-42/1-40 Ratio: Amyloid-beta 1-42 to 1-40 Ratio in Cerebrospinal Fluid
CSF tTau: Total Tau in Cerebrospinal Fluid
CSF pTau: Phosphorylated Tau in Cerebrospinal Fluid
Hippocampal Volume: Hippocampal Volume by MRI Volumetry
Ventricular Volume: Ventricular Volume by MRI Volumetry
Whole Brain Atrophy: Whole Brain Atrophy by MRI Volumetry
18F-Florbetapir PET SUVR: 18F-Florbetapir Positron Emission Tomography Standardized Uptake Value Ratio
API ADAD Composite Cognitive Test: API ADAD Composite Cognitive Test Total Score
WBV: Whole Brain Volume (mL)
Florbetapir SUVR: Florbetapir cortical‑to‑cerebellar uptake ratio
Executive Function CFA: Executive Function ability from Confirmatory Factor Analysis
STROOP: Stroop Test
ADAS-cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
EXAMINER: NIH EXAMINER Executive Function Battery
M/EEG: Magnetoencephalogram/Electroencephalogram
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Scale
VNAV: Virtual Navigation Test
CAF: Clinician Assessment of Fluctuation
ODFAS: One Day Fluctuation Assessment Scale
NPI: Neuropsychiatric Inventory
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
CDR-SOB: Clinical Dementia Rating Sum of Boxes
LEV: Levetiracetam serum level
PRL: Prolactin level
NPI-A: Neuropsychiatric Inventory Anxiety Item
NPI: Neuropsychiatric Inventory Total Score
ADCS-ADL23: Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory 23-item Total Score
EQ-5D VAS: EuroQol 5-Dimension Visual Analogue Scale
EQ-5D Utility: EuroQol 5-Dimension Utility Index
MMSE: Mini Mental State Examination Total Score
ADAS-cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale Total Score
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change Score
NPI: Neuropsychiatric Inventory total score
NPI Anxiety Item: Neuropsychiatric Inventory anxiety item score
NPI Single Item Score: Individual Neuropsychiatric Inventory item score
EQ-5D: EuroQol 5‑Dimensional utility score
EQ-5D VAS: EuroQol 5‑Dimensional Visual Analogue Scale
MMSE: Mini Mental State Examination
ADAS-cog: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale total score
ADCS-ADL23: Alzheimer’s Disease Cooperative Study Activities of Daily Living Inventory total score
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impression of Change score
CDR: Clinical Dementia Rating
MMSE: Mini‑Mental State Examination
PFAQ: Pfeffer Functional Activities Questionnaire
CDR-SB: Clinical Dementia Rating Sum of Boxes
SUVr: Flortaucipir Standardized Uptake Value Ratio
τAD++: Advanced Alzheimer’s Disease Status
RVP A' prime: Signal detection measure of target sensitivity (0-1)
RVP Median Latency: Median latency in milliseconds (100-1900)
VRM Immediate Recall: Correct responses (0-18)
VRM Delayed Recall: Correct responses (0-18)
SWM Errors: Number of errors (0-1040)
PAL Errors: Number of errors (0-91)
VITALS%: Percentage of participants with markedly abnormal vital signs
LAB%: Percentage of participants with markedly abnormal standard safety laboratory values
PROTOCOL%: Percentage of participants meeting markedly abnormal criteria specified by protocol
TEAE: Treatment‑Emergent Adverse Event count
OCL Percent: OCL Visual Recognition Task Percentage Correct
OCL Arc: OCL Visual Recognition Task Arcsine Transformation
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
MMSE: Mini Mental State Examination
ADCS-ADL23: Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinical Global Impression of Change
NPI: Neuropsychiatric Inventory
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
ADCS-CGIC: Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change
ADAS-cog: Alzheimer's Disease Assessment Scale-cognitive subscale
NPI: Neuropsychiatric Inventory
DEMQOL-Proxy: DEMQOL‑Proxy Questionnaire
CDR: Clinical Dementia Rating Scale
ADAS-cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
THA: Total Hippocampus Atrophy to Intracranial Volume ratio
COWAT: Controlled Oral Word Association Test
MMSE: Mini-Mental State Examination
SUVR PET: Standardized Uptake Value Ratio Positron Emission Tomography
MMSE: Mini‑Mental State Examination
NPI‑Q: Neuropsychiatric Inventory Questionnaire
TEAE: Treatment‑Emergent Adverse Event
SAE: Serious Adverse Event
NRI: Net Reclassification Index
CV_PiB: Coefficient of variation for 11C‑PiB SUVr
CV_Florbetapir: Coefficient of variation for florbetapir (18F) SUVr
CC_PiB-Florbetapir: Correlation coefficient between 11C‑PiB and florbetapir (18F) SUVr
CL_Florbetapir: Conversion of florbetapir (18F) PET SUVr to Centiloid units
CorticalAvg_Cereb_SUVr: Cortical average to cerebellum Standard Uptake Value Ratio
ADAS-cog11: Alzheimer Disease Assessment Scale – Cognitive 11
MMSE: Mini-Mental State Examination
ADCS-ADL: Alzheimer Disease Cooperative Study Activities of Daily Living Inventory
CDR-SO: Clinical Dementia Rating Sum of Boxes
CSF Tau: Tau protein in cerebrospinal fluid
CSF Aβ1-42: Amyloid‑beta 1‑42 in cerebrospinal fluid
Brain Volume: Regional brain volume change
FDG-PET: Brain glucose uptake measured by F18‑FDG positron emission tomography
Adverse Effects: Monitoring of drug versus placebo adverse events
ApoE Genotype: Apolipoprotein E genotype
DPC: Donepezil Plasma Concentration (pre‑dose and 4‑hour post‑dose)
TEAE: Treatment‑Emergent Adverse Event
DMTD: Donepezil Maximum Tolerated Dose
ADAS-COG: Alzheimer’s Disease Assessment Scale – Cognitive Subscale
MMSE: Mini Mental Status Examination
RBANS: Repeatable Battery for the Assessment of Neuropsychological Status
WAIS-IV: Wechsler Adult Intelligence Scale – Fourth Edition
DKEFS: Delis‑Kaplan Executive Function System Color‑Word Test
Graphomotor Condition 4: Number Letter Switching
CMRgl Medial Temporal Region: Cerebral Metabolic Rate for Glucose in medial temporal structures
CMRgl Prefrontal Cortex: Cerebral Metabolic Rate for Glucose in prefrontal cortex
CMRgl Parietotemporal Cortex: Cerebral Metabolic Rate for Glucose in parietotemporal cortex
CMRgl Posterior Cingulate Cortex: Cerebral Metabolic Rate for Glucose in posterior cingulate cortex
sROI: Summary Index of Regional Brain Activity
Mg RBC: Magnesium concentration in red blood cells
HVLT-R: Hopkins Verbal Learning Test‑Revised Delayed Recall
RBANS Figure Recall: Repeatable Battery of Assessments for Neuropsychological Status Figure Recall
Digit Symbol Coding: Digit Symbol Coding Test
CDR-SB: Clinical Dementia Rating‑Sum of Boxes
MMSE-2: Mini‑Mental State Exam version 2
PK Parameters: Cmax, Tmax, AUClast
TC: Total Cholesterol
DP: Diastolic Pressure
SP: Systolic Pressure
MMEE: Mini Mental Evaluation Exam
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Scale – Sum of Boxes
ADAS-cog11: Alzheimer's Disease Assessment Scale – Cognitive Subscale (11-item)
NTB: Neuropsychological Test Battery
ADCS-ADL: Alzheimer's Disease Cooperative Study – Activities of Daily Living
MMSE: Mini‑Mental State Examination
APOE4: Apolipoprotein E4 allele
CSFpTau: Cerebrospinal fluid phosphorylated tau
CSFtTau: Cerebrospinal fluid total tau
PlasmaAβ1-40: Plasma Amyloid‑beta 1‑40
PlasmaAβ1-42: Plasma Amyloid‑beta 1‑42
Florbetapir PET SUVR: Florbetapir amyloid PET Standard Uptake Value Ratio
Centiloid: Centiloid scale for amyloid PET
TauPET SUVR: Flortaucipir PET Standard Uptake Value Ratio
FDGPET SUVR: Fluorodeoxyglucose PET Standard Uptake Value Ratio
MRIWBV: Magnetic Resonance Imaging whole brain volume
iADRS: Integrated Alzheimer’s Disease Rating Scale
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13‑item
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
CDR-SB: Clinical Dementia Rating – Sum of Boxes
CDRGLOBAL: Clinical Dementia Rating Global score
NPI: Neuropsychiatric Inventory
FAQ: Functional Activities Questionnaire
QualRead: Qualitative read results of flortaucipir uptake
SUVr: Standard Uptake Value Ratio of flortaucipir
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
SRT: Buschke Selective Reminding Test Immediate Total Score
NPI: Neuropsychiatric Inventory
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
Cerebellum_L: Left cerebellar composite region
Cerebellum_R: Right cerebellar composite region
Paracentral_Lobule_L: Left paracentral lobule
Paracentral_Lobule_R: Right paracentral lobule
FLAIR: Fluid-Attenuated Inversion Recovery
T1: T1-weighted MRI sequence
FAQ: Functional Assessment Questionnaire
MMSE: Mini-Mental State Examination
TEAE: Treatment-Emergent Adverse Event
SAE: Serious Adverse Event
QTcF: Corrected QT interval using Fridericia's formula
ABETA(1-x)-plasma: Amyloid beta (1-x) in plasma
ABETA(1-42)-CSF: Amyloid beta 1-42 in cerebrospinal fluid
LHVC: Left Hippocampal Volume
RHVC: Right Hippocampal Volume
THV: Total Hippocampal Volume
WBV: Whole Brain Volume
TVV: Total Ventricular Volume
vMRI: volumetric Magnetic Resonance Imaging
UIR: Integrated Urine Radioactivity
NTB Z-score: Neuropsychological Test Battery total z‑score
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADAS-cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale
NPI-Apathy: Neuropsychiatric Inventory Apathy Subscale Score
CGIC: Clinical Global Impression of Change
CGIC Improvement %: Percentage of participants with minimal/moderate/marked improvement on CGIC
ChairStandTime: Time to complete 5 chair stands without using arms in seconds
QOL-AD: Quality of Life Scale in Alzheimer's Disease
ADAS-cog: Alzheimer's Disease Assessment Scale – Cognitive Subscale
FallsEfficacyScale: Standard measure of falls efficacy asking about concern about falling
GDS: Geriatric Depression Scale short form
SPPB: Short Physical Performance Battery
DAD: Disability Assessment for Dementia
NPI-FS: Neuropsychiatric Inventory – Frequency*Severity subscale
NPI: Neuropsychiatric Inventory
PositiveCaregivingScale: Standard measure rating agreement/disagreement with 11 statements about positive aspects of caregiving
CaregiverQoL: Caregiver assessment of participant's quality of life
CaregiverDistressScale: Measure of caregiver distress associated with 12 common dementia-related behaviors
CaregiverSatisfactionSurvey: Anonymous satisfaction survey after completion or withdrawal
CBI: Caregiver Burden Inventory
ToeReachFlexibility: Measure of flexibility reaching toward toes
ConeWalkMobility: Measure of mobility timed around a cone
Flortaucipir Whole Cortex SUVR: Flortaucipir PET Standard Uptake Value Ratio for whole cortex
Flortaucipir Occipital SUVR: Flortaucipir PET Standard Uptake Value Ratio for occipital composite
Flortaucipir Parietal SUVR: Flortaucipir PET Standard Uptake Value Ratio for parietal composite
Flortaucipir Limbic SUVR: Flortaucipir PET Standard Uptake Value Ratio for limbic composite
Flortaucipir Cingulate SUVR: Flortaucipir PET Standard Uptake Value Ratio for cingulate composite
Flortaucipir Frontal SUVR: Flortaucipir PET Standard Uptake Value Ratio for frontal composite
Flortaucipir Temporal SUVR: Flortaucipir PET Standard Uptake Value Ratio for temporal composite
AT8 Immunohistology: AT8 antibody‑based measurement of tau pathology
Letter Fluency: Verbal fluency test measuring number of acceptable words starting with specified letters
NPI: Neuropsychiatric Inventory
FDG-PET SUVR: Standard Uptake Value Ratio from FDG-PET
QoL-AD: Quality of Life – Alzheimer’s Disease scale
ADAS-Cog 11: Alzheimer's Disease Assessment Scale – Cognitive 11
Digit Span: Forward and Backward Digit Span test
MMSE: Mini Mental Status Examination
ADCS-ADL: Alzheimer's Disease Cooperative Study-Activities of Daily Living
SUV StdDev: Standard Deviation of Standardized Uptake Values from Normal Database
SUVr: Standardized Uptake Value Ratio
PCG SUV StdDev % change: Percent change in SUV StdDev in posterior cingulate gyrus
Parietal SUV StdDev % change: Percent change in SUV StdDev in parietal region
Anterior CG SUV StdDev % change: Percent change in SUV StdDev in anterior cingulate gyrus
Frontal SUV StdDev % change: Percent change in SUV StdDev in frontal region
Precuneus SUV StdDev % change: Percent change in SUV StdDev in precuneus region
Whole Brain Cortex SUVr % change: Percent change in SUVr in whole brain cortex relative to cerebellum
PCG SUVr % change: Percent change in SUVr in posterior cingulate gyrus
Parietal SUVr % change: Percent change in SUVr in parietal region
Frontal SUVr % change: Percent change in SUVr in frontal region
Anterior CG SUVr % change: Percent change in SUVr in anterior cingulate gyrus
Precuneus SUVr % change: Percent change in SUVr in precuneus region
QUALID: Quality of Life in Late Stage Dementia score change
MMSE: Mini Mental Status Exam score change
ADAS-Cog: Alzheimer’s Disease Assessment Scale Cognitive subscale score change
CTCAE: Common Terminology Criteria for Adverse Events total score change
AMYVID PET amyloid burden change: Change in amyloid plaque burden on AMYVID PET imaging
AMYVID PET amyloid positivity: Binary positive/negative determination using AMYVID criteria
QOL-AD: Alzheimer’s Quality of Life Questionnaire score change
ABeta 1-37: CSF Amyloid Beta 1-37
ABeta 1-38: CSF Amyloid Beta 1-38
ABeta 1-40: CSF Amyloid Beta 1-40
ABeta 1-42: CSF Amyloid Beta 1-42
ABeta 1-38: Plasma Amyloid Beta 1-38
ABeta 1-40: Plasma Amyloid Beta 1-40
ABeta 1-42: Plasma Amyloid Beta 1-42
Tau: Tau protein in CSF
pTau: Phosphorylated Tau protein in CSF
sAPP: Soluble Amyloid Precursor Protein alpha fragment in CSF
sAPP: Soluble Amyloid Precursor Protein beta fragment in CSF
CDR: Clinical Dementia Rating Scale score
TEAE: Treatment‑Emergent Adverse Event
SAE: Serious Adverse Event
CSF/Plasma Drug Concentration Ratio: Ratio of cerebrospinal fluid to plasma drug concentration
TEAE Count: Number of patients with severe or serious adverse events
CSF IL-8: Interleukin‑8 level in cerebrospinal fluid
HVLT Total Recall: Hopkins Verbal Learning Test total recall score
SIB: Severe Impairment Battery
ADCS-ADL-SEV: Alzheimer’s Disease Cooperative Study Activities of Daily Living Inventory – Severe Impairment Version
MMSE-2: Mini‑Mental State Examination‑2
NPI: Neuropsychiatric Inventory
CGI-I: Clinical Global Impression‑Improvement
AE: Adverse Event
SAE: Serious Adverse Event
Myalgia: Myalgia
RUD: Resource Utilization in Dementia
PGIC: Patient Global Impression of Change
NPI: Neuropsychiatric Inventory
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impressions of Change
ADAS-cog: Alzheimer’s Disease Assessment Scale Cognitive Subscale
MMSE: Mini-Mental State Examination
CMAI: Cohen‑Mansfield Agitation Inventory
CGIS-Agitation: Clinical Global Impression of Severity – Agitation
GMHR: Global Medical Health Rating
DEMQOL: Dementia Quality of Life Questionnaire
DEMQOL-proxy: Dementia Quality of Life Questionnaire Proxy
CSDD: Cornell Scale for Depression in Dementia
ZBI: Zarit Burden Interview
PGIC: Patient Global Impression of Change
CGIS-Agitation: Clinician Global Impression of Illness Severity – Agitation
NPI: Neuropsychiatric Inventory
RUD: Resource Utilization in Dementia
DEMQOL: Dementia Quality of Life
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impressions of Change
mADCS-CGIC-Agitation: Modified ADCS-CGIC for Agitation
CMAI: Cohen‑Mansfield Agitation Inventory
ZBI: Zarit Burden Interview
ADAS: Alzheimer’s Disease Assessment Scale
GMHR: Global Medical Health Rating
CSDD: Cornell Scale for Depression in Dementia
Barthel Index: Barthel Index score for activities of daily living
NPI: Neuropsychiatric Inventory total score
MMSE: Mini Mental State Examination score
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
Glucose: Fasting Blood Glucose Level
LDL: Low‑Density Lipoprotein Cholesterol
HDL: High‑Density Lipoprotein Cholesterol
Salivary Cortisol: Cortisol concentration in saliva
Body Mass: Body Mass Measurement
Skin Fold: Skin‑Fold Thickness Measurement
FFM: Estimated Fat Free Mass
Actiheart EE: Daily Energy Expenditure
MMSE: Mini-Mental State Examination
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADCS-ADL-MCI: Alzheimer’s Disease Cooperative Study Activities of Daily Living – Mild Cognitive Impairment version
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13-item
PSS: Perceived Stress Scale
DBS: Dementia Behavior Scale
CBS: Conditional Bother Score
FLORTAU: flortaucipir PET imaging for detecting neurofibrillary tangles
B SCORE: Braak staging score ranging from B0 to B3
KAPPA: Fleiss' Kappa statistic for inter-reader agreement
MAJINT: majority interpretation of AD pattern tau PET scan
NIA-AA: National Institute on Aging‑Alzheimer’s Association autopsy diagnosis
ADNC: Alzheimer’s disease neuropathologic change categories (None, Low, Intermediate, High)
NFT: neurofibrillary tangle
MAD: Maximum Tolerated Dose
TEAE: Treatment‑Emergent Adverse Event
LSIR: Local Tolerability at Injection Site
ARIA: Amyloid-Related Imaging Abnormalities
VS: Vital Signs
PE: Physical Examination
ECG: Electrocardiogram
LAB: Laboratory Tests
AE: Adverse Events
SAE: Serious Adverse Events
ADCS-CGIC: Alzheimer's Disease Cooperative Study - Clinical Global Impression of Change
AE: Adverse Events
DSST: Digit Symbol Substitution Test total correct
TEAE: Number of participants with treatment related adverse events
ADAS-Cog 11: Alzheimer's Disease Assessment Scale Cognitive Subscale 11
GoF: Global Efficiency (BOLD fMRI connectivity parameter)
delta R CMRgl: Change in relative brain glucose metabolism
sROI index: Spared region index
sROI index (WM): White matter index
delta sROI: Change in spared region index
NfL: Light Chain Neurofilament
RBANS: Repeatable Battery for the Assessment of Neurological Status
CDR: Clinical Dementia Rating
CDR-SOB: Clinical Dementia Rating Sum of Boxes
ECog: Everyday Cognition Scale
WB: Whole Brain
Hip: Hippocampus
LV: Lateral Ventricle
ARIA-E: Amyloid Related Imaging Abnormality-Edema
ARIA-H: Amyloid Related Imaging Abnormality-Hemorrhage
CAA: Cerebral Amyloid Angiopathy
MMSE: Mini-Mental State Examination
RPM: Raven's Progressive Matrices
APCC: Alzheimer’s Performance Composite Cognitive score
C-SSRS: Columbia-Suicide Severity Rating Scale
Cmax: Maximum plasma concentration
Racc: Accumulation ratio
CLss/F: Apparent systemic clearance at steady state
Tlag: Time lag to first detectable concentration
Tmax: Time to maximum concentration
T1/2: Terminal elimination half‑life
AUCtau: Area under the plasma concentration‑time curve over a dosing interval
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
CDR-SB: Clinical Dementia Rating Sum of Boxes
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Inventory
MMSE: Mini-Mental State Examination
NPI: Neuropsychiatric Inventory
ADAS-Cog-13: 13‑Item Alzheimer’s Disease Assessment Scale‑Cognitive Subscale
ADAS-Cog-11: 11‑Item Alzheimer’s Disease Assessment Scale‑Cognitive Subscale
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living Scale
DS: Dementia Severity Scale
CIBIC+: Clinician Interview-Based Impression of Change Plus
NPI: Neuropsychiatric Inventory
AE: Adverse Event
ECG: Electrocardiogram
VS: Vital Signs Measurements
PE: Physical Examination
LAB: Clinical Laboratory Assessments
OOA: Oxaloacetate Concentration in Plasma
DLT: Dose Limiting Toxicity Events
SL: Safety Lab Values
VITAL: Vital Sign Measurements
CM: Cognitive Measure Scores
CGIC: Global Impression of Change rating
ADCS-MCI-ADL: Alzheimer’s Disease Cooperative Study Mild Cognitive Impairment Activities of Daily Living
PSQI: Pittsburgh Sleep Quality Index
cNTB: Comprehensive Neuropsychological Test Battery composite score
ISLT: International Shopping List Test
OCL: One Card Learning
IDN: Identification
DET: Detection
OBK: One Back Card
COWAT: Controlled Oral Word Association Test
CFT: Categorical Fluency Test
NPI: Neuropsychiatric Inventory
ADAS-cog14: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale 14-item
AE: Adverse Event count
Organ ED: Effective Dose to organ from [11C]MK-6884
Whole Body ED: Effective Dose to whole body from [11C]MK-6884
BPND: Binding Potential Non‑Displaceable of [11C]MK-6884 in brain ROI
T-RT Variability: Test‑Retest variability of BPND (%)
SUV: Standard Uptake Value of [11C]MK-6884 in brain ROI
AUC: Area Under Curve of [11C]MK-6884 uptake
AUC: Area Under the Concentration-Time Curve
Cmax: Maximum Serum Concentration
AUCτ: Area Under the Curve at Steady State
TE‑ADA: Treatment Emergent Anti‑Drug Antibody
Fluorbetapir PET SUVR: Florbetapir Positron Emission Tomography Standard Uptake Value Ratio
EQ-5D: EuroQol Five Dimensions Health Status Measure
ADAS-Cog-13: Alzheimer's Disease Assessment Scale – Cognitive Subscale 13-item
MMSE: Mini-Mental State Examination
ABETA42-P: Plasma Amyloid-beta 42
QoL-AD: Quality of Life – Alzheimer’s Disease
AE: Adverse Event
ADCS-ADL: Alzheimer's Disease Cooperative Study – Activities of Daily Living
ADA: Antidrug Antibody
CDR-GS: Clinical Dementia Rating – Global Summary
ZCI-AD: Zarit Caregiver Interview – Alzheimer’s Disease
NPI-Q: Neuropsychiatric Inventory Questionnaire
CDR-SB: Clinical Dementia Rating – Sum of Boxes
CRNZ: Crenezumab Serum Concentration
ADAS-Cog-11: Alzheimer's Disease Assessment Scale – Cognitive Subscale 11-item
ADCS-iADL: Alzheimer's Disease Cooperative Study – Instrumental Activities of Daily Living
WBV%: Whole Brain Volume Percent Change
VV%: Ventricular Volume Percent Change
HV%: Hippocampal Volume Percent Change
PET: Positron Emission Tomography amyloid scan result
PD-Before: Physician Diagnosis before PET
PD-After: Physician Diagnosis after PET
DC: Diagnostic Confidence Likert scale
LP: Lumbar Puncture Failure Count
QOL-AD: Quality of Life – Alzheimer’s Disease Score
NPI-10: Neuropsychiatric Inventory 10‑Item Score
MMSE: Mini Mental State Evaluation
FUQ: Formulation Usability Questionnaire
MCS: Modified Crichton Scale
JCGIC: Japanese Clinical Global Impression of Change
FDG-PET: 18F-fluorodeoxyglucose positron emission tomography measurement of brain glucose uptake
AcAc-PET: 11C-acetoacetate positron emission tomography measurement of brain acetoacetate uptake
ADCS-PACC: Alzheimer’s Disease Cooperative Study Preclinical Alzheimer's Cognitive Composite
Aβ42: Cerebrospinal fluid beta‑amyloid‑42
tTau: Cerebrospinal fluid total tau
pTau-181: Cerebrospinal fluid phosphorylated tau‑181
PCC CBF: Posterior cingulate gyrus cerebral blood flow
PEDV: Emergency Department Visits
HAD: Hospital Admissions
PCDS: Palliative Care Domain Score
FDAD: Family Distress in Advanced Dementia Instrument
CAD-EOLD: Comfort at the End of Life in Dementia Instrument
POLST: Physician Orders for Life Sustaining Treatment
HOSPREF: Hospice Referral Rate
BTCOUNT: Burdensome Treatments Count
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
ADCOMs: AD Composite Scores
ADAS-Cog v14: Alzheimer’s Disease Assessment Scale – Cognitive Subscale Version 14
MMSE: Mini‑Mental State Examination
RAVLT: Rey Auditory Verbal Learning Test
COWAT: Controlled Oral Word Association Test
CFT: Total Correct Response
NPI: Neuropsychiatric Inventory
NTB: Neuropsychological Test Battery
AUC: Area Under the Curve
Cmax: Maximum Concentration
QTcF: Corrected QT Interval using Fridericia's Formula
SAE: Serious Adverse Event Count
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
APOE: Apolipoprotein E genotype
MMSE: Mini-Mental State Examination
CIBIC+: Clinician's Interview-Based Impression of Change
CIBIS: Clinician's Interview-Based Impression of Severity
MMSE: Mini Mental State Examination
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
ARIA-E: Amyloid‑related imaging abnormalities‑edema
ARIA-H: Amyloid‑related imaging abnormalities‑hemorrhage
iADRS: Integrated Alzheimer’s Disease Rating Scale
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive subscale 13 item
ADCS-iADL: Alzheimer’s Disease Cooperative Study – Instrumental Activities of Daily Living
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
C-SSRS: Columbia Suicide Severity Rating Scale
PK-AUC[T,SS]: Area Under Curve (Time, Steady State) of LY3202626
Plasma Aβ1-40: Plasma Amyloid‑Beta 1‑40 Concentration
Plasma Aβ1-42: Plasma Amyloid‑Beta 1‑42 Concentration
Plasma Aβ1-x: Plasma Amyloid‑Beta 1‑x Concentration
ADAS: Alzheimer’s Disease Assessment Scale (Overall)
18F-AV-1451 PET SUVr: Tau PET Standardized Uptake Value Ratio
TE MRI Findings: Treatment‑Emergent MRI Findings
AE: All Adverse Events
PAS: Pittsburgh Agitation Scale
NPI-C: Neuropsychiatric Inventory Clinician Version
SUVr: Standardized Uptake Value Ratio
TSPO SUVR: Standardized Uptake Value Ratio of Translocator Protein
ABeta SUVR: Standardized Uptake Value Ratio of Amyloid‑Beta protein
CSF Protein Analysis: Cerebrospinal Fluid Protein Analysis
MFVFT: Modified Fuld Verbal Fluency Test
MoCA-HK: Hong Kong version of the Montreal Cognitive Assessment
FOme: Fuld Object Memory Evaluation
MAI: Medication Appropriateness Index
MoCA: Montreal Cognitive Assessment
TMT‑B: Trail Making Test B
CVLT‑II: California Verbal Learning Test – Second Edition
SF‑36: Short Form Health Survey
ADAS-Cog12: Alzheimer’s Disease Assessment Scale-Cognitive 12
NPI: Neuropsychiatric Inventory
MMSE: Mini-Mental State Examination
POSIPHEN TARTRATE: Posiphen Tartrate
POSIPHEN N1 DESMETHYL: N1 Desmethyl Posiphen
POSIPHEN N8 DESMETHYL: N8 Desmethyl Posiphen Metabolite
FSR-Aβ40: Fractional Synthesis Rate of Amyloid‑beta 40 in CSF
Aβ38: Amyloid‑beta 38 in CSF
Aβ40: Amyloid‑beta 40 in CSF
Aβ42: Amyloid‑beta 42 in CSF
sAPPα: Soluble Amyloid Precursor Protein Alpha in CSF
sAPPβ: Soluble Amyloid Precursor Protein Beta in CSF
T-Tau: Total Tau in CSF
PLASMA POSIPHEN TARTRATE: Posiphen Tartrate in Plasma
PLASMA POSIPHEN N1 DESMETHYL: N1 Desmethyl Posiphen in Plasma
PLASMA POSIPHEN N8 DESMETHYL: N8 Desmethyl Posiphen Metabolite in Plasma
CSF VOLUME: CSF Sample Volume Sufficiency
AE: Adverse Events
SD: Study Discontinuations
ADAS-cog14: Alzheimer's Disease Assessment Scale – Cognitive Subscale 14-item version
ADAS-cog11: Alzheimer's Disease Assessment Scale – Cognitive Subscale 11-item version
MMSE: Mini-Mental State Examination
ADCOMS: Alzheimer's Disease Composite Scoring System
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
FAQ: Functional Assessment Questionnaire
Amyloid PET: Positron Emission Tomography for cerebral amyloid load
SUVR: Standardized Uptake Value Ratio
CENTILOID: Centiloid scale for amyloid burden
TEAE: Treatment-Emergent Adverse Event
Conversion to dementia: Time to conversion to dementia
CDR-SB slope: Annual change in CDR Sum of Boxes
ADAS-Cog13: 13‑item version of ADAS‑Cog
iADRS: Integrated Alzheimer’s Disease Rating Scale
FAQ: Functional Activity Questionnaire
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
ADCS-iADL: Alzheimer’s Disease Cooperative Study Instrumental Activities of Daily Living
MMSE: Mini‑Mental State Examination
MMSE: Mini-Mental State Examination
TEAE: Treatment-Emergent Adverse Events Count
SAE: Serious Adverse Events Count
DRS: Dermal Response Score
UTI: Urinary Tract Infection Presence
ADCS-ADL SIV: Alzheimer's Disease Cooperative Study Activities of Daily Living Severe Impairment Version Score
PAS: Patch Adhesion Score
CMQ: Caregiver Medication Questionnaire Compliance Score
CMAI: Cohen-Mansfield Agitation Inventory
ZBI: Zarit Burden Interview
AE: Adverse Events
SAE: Serious Adverse Events
CMAX: Peak plasma concentration
AUC0-TAU: Area Under Curve from zero to infinity
PMLC: Pearlin Mastery, Loss, and Competence instrument
Caregiving Competence Subscale: Pearlin Mastery, Loss, and Competence instrument subscale
Management of Situation Subscale: Pearlin Mastery, Loss, and Competence instrument subscale
PSS: Perceived Stress Scale
CESD-R: Center for Epidemiologic Studies Depression Scale Revised
ZBI: Zarit Burden Interview
RMBPC: Revised Memory and Behavior Problems Checklist
STAI-S: Spielberger State‑Trait Anxiety Inventory – State version
IADL: Instrumental Activities of Daily Living Scale (Lawton Brody)
MMSE: Mini Mental State Examination
D-KEFS Trail: Delis-Kaplan Executive Function Trail Number-Letter Switching Scaled Score
HVLT-R: Hopkins Verbal Learning Test-Revised Recall
LDSF: Longest Digit Span Forward
LDSB: Longest Digit Span Backward
NPI: Neuropsychiatric Inventory
FAS: Letter Fluency (FAS)
BVD: Benton Visual Form Discrimination
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive subscale
DRS: Dementia Rating Scale
Computerized Attention Task RT: Response Time to Detect Target
Computerized Attention Task Accuracy: Accuracy of Reporting Stimuli
Computerized Attention Task Variability: SD of Response Time
EF: Executive Function Score
GCP70: Global Cognitive Performance Scale (0-70)
GCP30: Global Cognitive Performance Scale (0-30)
Memory Function Score: Memory Function Scale
Memory Performance Score: Memory Performance Scale
AE: Adverse Events
COX: Cytochrome Oxidase Activity
CS: Citrate Synthase Activity
COX/CS Ratio: Cytochrome Oxidase to Citrate Synthase Activity Ratio
NPI-Q: Neuropsychiatric Inventory Questionnaire
FAQ: Functional Activities Questionnaire
ADAS-Cog-13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13-item version
ADAS-Cog-11: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 11-item version
ADCS-iADL: Alzheimer’s Disease Cooperative Study – Instrumental Activities of Daily Living
ADCS-ADL: Alzheimer’s Disease Cooperative Study – Activities of Daily Living
MMSE: Mini-Mental State Examination
CDR-GS: Clinical Dementia Rating Global Score
CDR-SB: Clinical Dementia Rating – Sum of Boxes
EQ-5D: EuroQol Five Dimensions
ZCI-AD: Zarit Caregiver Interview – Alzheimer’s Disease modified version
QoL-AD: Quality of Life – Alzheimer’s Disease
AE: Adverse Event
ABETA42: Plasma Amyloid Beta 42
ABETA40: Plasma Amyloid Beta 40
ABETA42/40 Ratio: Plasma Amyloid Beta 42 to 40 ratio
LP-PLA2: Lipoprotein-associated Phospholipase A2 activity
Hippocampal Volume %: Percentage change in hippocampal volume
Whole Brain Volume %: Percentage change in whole brain volume
Ventricular Volume %: Percentage change in ventricle volume
CRENEZUMAB: Crenezumab Serum Concentration
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
GDS: Geriatric Depression Scale
AE: Adverse Events
NPI: Neuropsychiatric Inventory
MMSE: Mini-Mental State Examination
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
C-SSRS: Columbia Suicide Severity Rating Scale
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
TEAEs: Treatment Emergent Adverse Events
NPI-CD: NPI-Caregiver Distress score
NPI: NPI total score
BI4: Behavioral Intention 4-item scale
SUS: modified System Usability Scale score
RR: Recruitment rate
DC: Data completeness count
ACH: All‑cause hospital and emergency room admission count
ECog: Everyday Cognition Scale
t-tau: total tau protein
p-tau: phosphorylated tau protein
Aβ40: Amyloid Beta 40
Aβ42: Amyloid Beta 42
NfL: Neurofilament Light Chain
RBANS: Repeatable Battery for the Assessment of Neurological Status
MMSE: Mini-Mental State Examination
RPM: Raven's Progressive Matrices
APCC: APCC composite score derived from RBANS, MMSE, RPM
CDR: Clinical Dementia Rating
CDR-SOB: Clinical Dementia Rating Sum of Boxes
C-SSRS: Columbia-Suicide Severity Rating Scale
ROI%Δ: Annualized % change from baseline in volume of specific brain regions of interest
ARIA-E: Amyloid Related Imaging Abnormality-Edema
ARIA-H: Amyloid Related Imaging Abnormality-Hemorrhage
DMN Connectivity: Strength of connection between posterior cingulate cortex and lateral parietal cortex (T‑score)
ADAS-cog: Alzheimer's Disease Assessment Scale‑Cognitive Subscale
NPI: Neuropsychiatric Inventory
GDS: Geriatric Depression Scale – short form
QOL-AD: Quality of Life in Alzheimer’s Disease
CBI: Caregiver Burden Index
PAC: Positive Aspects of Caregiving Scale
CDT: Clock‑Drawing Test
Brain Perfusion: Perfusion values normalized to precentral gyrus
CMAI: Cohen‑Mansfield Agitation Inventory Total Score
RBANS: Repeatable Battery for the Assessment of Neuropsychological Status
AMIADL: Amsterdam Instrumental Activities of Daily Living Questionnaire
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADAS-Cog-13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13-item version
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
SEMORINEMAB Serum Concentration: Serum concentrations of Semorinemab
ADA: Anti-Drug Antibody
CASA: Classification Algorithm for Suicide Assessment
C-SSRS: Columbia Suicide Severity Rating Scale
TEAE: Treatment-Emergent Adverse Event Rate
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
PET SUVR: Standardized Uptake Value Ratio
dSUVR: Difference in Standardized Uptake Value Ratio
Gamma Band Absolute Power: Absolute power density in the 35‑45 Hz band
Gamma Band Relative Power: Relative power density in the 35‑45 Hz band
%ΔRelPower: Percent change in relative spectral power
PHQ-9: Patient Health Questionnaire-9 Depression Scale
RSCE: Revised Scale for Caregiving Self Efficacy
SF-36: Short Form-36 Health Survey
GAD-7: Generalized Anxiety Disorder 7-item Scale
PCS: Preparedness for Caregiving Scale
SUVr: Standardized Uptake Value Ratio
TAU_AD_MINUS: Not consistent with AD pattern
TAU_AD_PLUS: Moderate AD pattern
TAU_AD_DOUBLEPLUS: Advanced AD pattern
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
FBPET SUVR: Florbetapir PET Standardized Uptake Value Ratio
CL: Centiloid scale
CDR-SB: Clinical Dementia Rating – Sum of Boxes
MMSE: Mini-Mental State Examination
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
iADRS: Integrated Alzheimer’s Disease Rating Scale
ADAS-Cog13: Alzheimer's Disease Assessment Scale – Cognitive Subscale 13-item
FLORTAU PET SUVR: Flortaucipir PET weighted average Standardized Uptake Value Ratio
TauIQ: TauIQ method for global tau load
TauL: Global tau load
vMRI: Volumetric MRI parameters
ADAS: Alzheimer's Disease Assessment Scale
SUVr: Standardized Uptake Value Ratio
MK-6240: 18F-MK-6240 binding
CSF-ND-Inflammation: CSF markers of neurodegeneration and inflammation
AB1-40: Amyloid beta 1-40
AB1-42: Amyloid beta 1-42
p-tau181: Phospho-Tau 181
p-tau181/AB1-42: Ratio of Phospho-Tau 181 to Amyloid beta 1-42
NFL: Neurofilament Light Chain
Neurogranin: Neurogranin
WMS Immediate Recall Composite: Wechsler Memory Scale Immediate Recall Composite
WMS Delayed Recall Composite: Wechsler Memory Scale Delayed Recall Composite
HVLT-R Total Recall Z-Score: Hopkins Verbal Learning Test – Revised Total Recall Z-Score
HVLT-R Delayed Recall Z-Score: Hopkins Verbal Learning Test – Revised Delayed Recall Z-Score
CDR-SB: Clinical Dementia Rating Scale – Sum of Boxes
MMSE: Mini-Mental State Examination
t-tau: Total Tau
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
ADAS-cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
NPI: Neuropsychiatric Inventory
CTT: Color Trails Test
CSF tau: Cerebrospinal Fluid Tau
plasma tau: Tau protein in plasma
CSF Aβ42: Amyloid Beta 1-42 in CSF
plasma Aβ42: Amyloid Beta 1-42 in plasma
CSF NfL: Neurofilament Light Chain in CSF
plasma NfL: Neurofilament Light Chain in plasma
ADAS-Cog: Alzheimer’s Disease Assessment Scale‑Cognitive Subscale score change
PET SUVR dSUVR: Difference in Standardized Uptake Value Ratio for microglia activation
Amyloid PET SUVR dSUVR: Difference in Standardized Uptake Value Ratio for amyloid load
Tau PET SUVR dSUVR: Difference in Standardized Uptake Value Ratio for tau deposition
ASL Perfusion Change: Mean change in arterial spin labeling perfusion
Depressive Symptoms %: Percent of nursing home residents with dementia who had depressive symptoms
Antipsychotic Medication %: Percent of nursing home residents with dementia who received one or more antipsychotic medication
Rejection of Care %: Percent of nursing home residents with dementia who had rejection of care
Physical Restraint Use %: Percent of nursing home residents with dementia who had physical restraint use
Unintended Weight Loss %: Percent of nursing home residents with dementia who had unintended weight loss
Behavioral Symptoms %: Percent of nursing home residents with dementia who had behavioral symptoms
Falls %: Percent of nursing home residents with dementia who had falls
Wandering %: Percent of nursing home residents with dementia who had wandering
ARIA: Amyloid-related imaging abnormalities
pTau: phosphorylated tau
tTau: total tau
DSST: Digit Symbol Substitution Test
ADA: Anti-drug Antibody
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
ADCS-iADL: Alzheimer's Disease Cooperative Study Instrumental Activities of Daily Living
NFL: Neurofilament Light Chain
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
ADAS-Cog13: Alzheimer's Disease Assessment Scale-Cognitive Subscale 13
Amyloid PET SUVR: Standardized Uptake Value Ratio of amyloid PET
FAQ: Functional Assessment Questionnaire
Tau PET SUVR: Standardized Uptake Value Ratio of tau PET
VFT: Verbal Fluency Task
MMSE: Mini-Mental State Examination
C-SSRS: Columbia-Suicide Severity Rating Scale
FAQ: Functional Assessment Questionnaire
ARIA: Amyloid-Related Imaging Abnormalities
Tau-PET SUVR: Standardized Uptake Value Ratio of tau PET
C-SSRS: Columbia Suicide Severity Rating Scale
DSST: Digit Symbol Substitution Test
CSF pTau: Cerebrospinal Fluid phosphorylated tau
CSF tTau: Cerebrospinal Fluid total tau
ADAS-Cog13: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 13-item
ADAS-Cog11: Alzheimer’s Disease Assessment Scale-Cognitive Subscale 11-item
Amyloid PET Centiloid: Amyloid PET Standardized Uptake Value Ratio mapped to centiloid scale
ADCS-iADL: ADCS Instrumental Activities of Daily Living
AE: Adverse Event
VFT: Verbal Fluency Task
MMSE: Mini-Mental State Examination
ADCS-ADL: ADCS Activities of Daily Living
NFL: Neurofilament Light Chain
ADA: Anti-Drug Antibody
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
τAD-: Flortaucipir PET visual read category Not consistent with AD pattern
τAD+: Flortaucipir PET visual read category Moderate AD pattern
τAD++: Flortaucipir PET visual read category Advanced AD pattern
SUVr: Flortaucipir standardized uptake value ratio
ADAS-Cog14: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 14
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13
ADAS-Cog11: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 11
MMSE: Mini-Mental State Examination
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADCS-CGIC: ADCS Clinician Global Impression of Change
ADCS-ADL: ADCS Activities of Daily Living
Cognitive Composite: Composite z‑score of selected ADAS‑Cog and NTB items
Memory Composite: Composite z‑score of ADAS‑Cog word recall, orientation, delayed word recall, word recognition
Executive Composite: Composite z‑score of CFT, Digit Span, TMT B
Attention Composite: Composite z‑score of Number Cancellation, Maze, TMT A
CSF Aβ40: Cerebrospinal fluid amyloid beta 1‑40
CSF Aβ42: Cerebrospinal fluid amyloid beta 1‑42
CSF tau: Cerebrospinal fluid total tau
CSF phospho‑tau: Cerebrospinal fluid phosphorylated tau
CSF neurogranin: Cerebrospinal fluid neurogranin
CSF synaptotagmin: Cerebrospinal fluid synaptotagmin
CSF SNAP25: Cerebrospinal fluid SNAP25
CSF NFL: Cerebrospinal fluid neurofilament light
FDG SUVR: 18F‑FDG Standardized Uptake Value Ratio
DVR: Distribution Volume Ratio (11C UCB‑J)','ICC: Intraclass Correlation Coefficient (resting‑state fMRI)
MMSE: Mini-Mental State Examination
ADAS: Alzheimer's Disease Assessment Scale
ADAS-Cog13: Alzheimer's Disease Assessment Scale-Cognitive Subscale 13
iADRS: Integrated Alzheimer's Disease Rating Scale
ADCS-iADL: Alzheimer's Disease Cooperative Study Instrumental Activities of Daily Living
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
C-SSRS: Columbia Suicide Severity Rating Scale
flortaucipir SUVr: Flortaucipir Standardized Uptake Value Ratio
vMRI: Volumetric Magnetic Resonance Imaging
TE-ADA: Therapeutic Antibody Drug Anti-Drug Antibody
MMSE: Mini-Mental State Examination
ADCS-ADL23: Alzheimer's Disease Cooperative Study Activities of Daily Living 23
ADCS-CGIC: Alzheimer's Disease Cooperative Study Clinician Global Impression of Change
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
NPI-Q: Neuropsychiatric Inventory Questionnaire
ADAS-Cog/11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
TEAE: Treatment-Emergent Adverse Events
Anti-Aβ: Anti‑beta amyloid antibody level in serum
MMSE: Mini-Mental State Examination
ADAS-Cog 13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13-item version
TEAEs: Treatment Emergent Adverse Events
CDR-SB: Clinical Dementia Rating – Sum of Boxes
TEAE: Treatment‑Emergent Adverse Event Count
GST: Global Statistical Test Composite Score
Hippocampal Volume: Volumetric Magnetic Resonance Imaging Measure
FAQ: Functional Activities Questionnaire Total Score
MoCA: Montreal Cognitive Assessment Score
NPI: Neuropsychiatric Inventory Total Score
ADAS-Cog: Alzheimer’s Disease Assessment Scale – Cognitive Subscale Score
DSRS: Dementia Severity Rating Scale Score
Adherence %: Percentage of completed flicker exposure sessions
Tolerance Likert: 1‑5 point Likert scale rating for brightness and loudness
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living
NPI: Neuropsychiatric Inventory
CDR-SB: Clinical Dementia Rating Sum of Boxes
MRI-HV: Hippocampal Volume derived from volumetric MRI
MRI-ETC: Entorhinal Cortical Thickness
MMSE: Mini-Mental State Examination
ADAS-Cog: Alzheimer's Disease Assessment Scale-Cognitive Subscale
APOE-e4: Apolipoprotein E ε4 allele
CGI-S: Clinical Global Impression – Severity
CGI-I: Clinical Global Impression – Improvement
CMAI: Cohen‑Mansfield Agitation Inventory
ARIA: Amyloid-related imaging abnormalities severity
Exercise Minutes per Week: Minutes spent on exercising per week
SF-36 PF: Physical Functioning subscale of the Medical Outcomes Study 36-Item Short Form
QOL-AD: Quality of Life in Alzheimer's Disease scale
NPI: Neuropsychiatric Inventory
NPI-NH: Neuropsychiatric Inventory – Nursing Home version
Caregiver Distress Scale: caregiver distress component of NPI
Occupational Disruptiveness Scale: occupational disruptiveness component of NPI‑NH
ADCS-CGIC-A: Alzheimer’s Disease Cooperative Study Clinical Global Impression – Agitation
ADCS-ADL-Severe: Alzheimer’s Disease Cooperative Study Activities of Daily Living – Severe
Lorazepam cumulative dose: cumulative total dose of rescue Lorazepam
C-SSRS: Columbia Suicide Severity Rating Scale
TEAE: Treatment Emergent Adverse Event
CTCAE: Common Terminology Criteria for Adverse Events
CMAI: Cohen‑Morgan Agitation Inventory
CGI‑I: Clinical Global Impression – Improvement
CGI‑S: Clinical Global Impression – Severity
SUVR: Standardized Uptake Value Ratio
VT: Total Distribution Volume
Cmax: Maximum plasma concentration
Half-life: Elimination half‑life
Last detection time: Time to last detectable concentration
AUC: Area Under the Curve
Aβ42: Amyloid Beta 1‑42
tau: Tau protein
YKL40: YKL‑40 (Chitinase‑3‑like protein 1)
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impression of Change
NPI-NH: Neuropsychiatric Inventory Nursing Home version
NPI: Neuropsychiatric Inventory
SIB: Severe Impairment Battery
MMSE: Mini-Mental State Examination
ADCS-ADL-Severe: Alzheimer’s Disease Cooperative Study Activities of Daily Living Severe
TEAE: Treatment‑Emergent Adverse Event
Completion Rate: Number of subjects completing 4 weeks after 5 infusions
Vz/F: Apparent Volume of Distribution
AUCextrap[%]: Percentage of AUC extrapolated to infinity
λz: Elimination rate constant
AUCinf: Area Under Curve extrapolated to infinity
T½: Terminal elimination half‑life
AUClast: Area Under Curve up to last measurable concentration
tlast: Time to last quantifiable concentration
Cmax: Peak drug concentration
CL/F: Apparent Oral Clearance
NAA/Cr: N-acetylaspartate to creatine ratio
LPI: Lumosity Performance Index
CLPI: Cognitive Lumosity Performance Index
RBANS: Repeatable Battery for the Assessment of Neuropsychological Status
RBANS: Repeatable Battery for the Assessment of Neuropsychological Status
RBANS DMI: Delayed Memory Index
CGI-I: Clinician Global Impression – Improvement
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
MMSE: Mini-Mental State Examination
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
ADAS-Cog 11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
PD≥4mm: Periodontal Pocket Depth ≥4 mm
WBV: Bilateral Whole Brain Volume
Pg-IgG: Anti-Porphyromonas gingivalis IgG in Serum
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
CDR-SB: Clinical Dementia Rating Sum of Boxes
NPI: Neuropsychiatric Inventory Total Score
MMSE: Mini-Mental State Examination Total Score
ADCS-ADL: Alzheimer's Disease Cooperative Study Activities of Daily Living Score
CDR-SB: Clinical Dementia Rating Sum of Boxes
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11-item
MMSE: Mini Mental State Examination
IL-1B: Interleukin 1B
IL-6: Interleukin 6
IL-5: Interleukin 5
IL-13: Interleukin 13
IL-8: Interleukin 8
IL-2: Interleukin 2
IL-4: Interleukin 4
IL-10: Interleukin 10
TNFα: Tumor Necrosis Factor alpha
GFAP: Glial Fibrillary Acidic Protein
PTau: Phosphorylated tau
Tau: Total tau
NF-L: Neurofilament Light
Ammonia: Ammonia levels
MMSE: Mini-Mental State Examination
ADAS-Cog 11: Alzheimer’s Disease Assessment Scale – Cognition test with 11 tasks
FLEISS: Fleiss' Kappa
COHEN: Cohen's Kappa
SENS: Sensitivity
SPEC: Specificity
PET18FAV1451: 18F-AV-1451 PET imaging
NFTB: NFT B score
ADNC: Alzheimer’s Neuropathologic Change category
FLORTAU: Flortaucipir F‑18 PET scan
τAD: τAD classification
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
MMSE: Mini-Mental State Examination
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale
FAQ: Pfeffer's Functional Activities Questionnaire
CDR Global: Clinical Dementia Rating Global Score
Flortaucipir PET: Flortaucipir F-18 positron emission tomography imaging of tau pathology
SUVR: Standardized Uptake Ratio
ARC: Annualized Rate of Change
BRAAK1: Braak Stage 1 (Transentorhinal Region Involvement)
CDR-SB: Clinical Dementia Rating – Sum of Boxes
ADAS-COG14: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 14 Item
IADL: Amsterdam Instrumental Activities of Daily Living score
FAQ: Functional Activities Questionnaire score
MMSE: Mini‑Mental State Examination
CSF-tau: Cerebrospinal Fluid Tau protein
p-tau181: Phosphorylated Tau 181
Aβ: Amyloid beta
FCC: Fluid Cognitive Composite
NIH Toolbox: National Institutes of Health Toolbox
NPI-Q: Neuropsychiatric Inventory Questionnaire
CDR: Clinical Dementia Rating
PT: Prothrombin Time
INR: International Normalized Ratio
AE-Anaphylaxis: Anaphylaxis events
AE-GI: Gastrointestinal symptoms
AE-LiverEnzymes: Elevated liver enzymes
AE-Seizures: Seizure events
MKD: Montelukast Discontinuation
RO7126209 Plasma Concentration: Plasma concentration of RO7126209
RO7126209 CSF Concentration: Cerebrospinal fluid concentration of RO7126209
RO7126209 PK Parameters: Pharmacokinetic parameters of RO7126209 derived from concentration‑time profiles
ADA Status: Presence of anti‑drug antibodies in participants
Adverse Events: Count of adverse events reported
MOCA: Montreal Cognitive Assessment
MARI: Microglial Activation Ratio
CSF Drug: Drug concentration in cerebrospinal fluid
Tau-CSF: Tau protein level in CSF
Aβ-CSF: Amyloid Beta protein level in CSF
IL-6-CSF: Interleukin‑6 level in CSF
CognScore: Cognitive test score (0‑30)
ADCOMS: AD Composite Score
ADAS-cog/11: Alzheimer's Disease Assessment Scale – Cognitive Subscale 11‑item version
ADAS-Cog/12: Alzheimer's Disease Assessment Scale – Cognitive Subscale 12‑item version
MMSE: Mini‑Mental State Examination
CDR-SB: Clinical Dementia Rating Scale – Sum of Boxes
PTau181 Plasma: Phosphorylated tau 181 in plasma
YKL-40: YKL‑40 protein in cerebrospinal fluid
NfL: Neurofilament light chain in cerebrospinal fluid
PTau181 CSF: Phosphorylated tau 181 in cerebrospinal fluid
Total tau: Total tau protein in cerebrospinal fluid
Neurogranin: Neurogranin protein in cerebrospinal fluid
Amyloid beta42: Amyloid beta 1‑42 in cerebrospinal fluid
FLNA Receptor Linkage Ratio: Ratio of receptor immunoblot bands to total FLNA
SavaDx: Novel plasma biomarker
Episodic Memory Pattern Box Test: Cognitive test assessing episodic memory
Spatial Working Memory Square Search Test: Cognitive test assessing spatial working memory
HC Vol: Hippocampal Volume
WM Comp Z: Working Memory Composite Z-score
CT: Cortical Thickness
Reasoning Comp Z: Reasoning Composite Z-score
AV-1451 SUVR: Temporal Tau Standardized Uptake Value Ratio
SP Comp Z: Speed of Processing Composite Z-score
WMI Vol: White Matter Hypointensities Volume
Amyloid SUVR: Amyloid Standard Uptake Value Ratio
BOLD Activation Betas: Blood Oxygenation Level Dependent Activation Betas
EM Comp Z: Episodic Memory Composite Z-score
Tau SUVR: Tau Standardized Uptake Value Ratio
Resting-State Segregation: System Segregation
SF-36: Short Form Health Survey 36-item questionnaire
QOL-AD: Quality of Life in Alzheimer’s Disease
PROMIS CF: Patient-Reported Outcomes Measurement Information System Cognitive Function Battery
FFT: Functional Fitness Test
ActiGraph: Accelerometer measuring sedentary time and physical activity
DRS: Dyadic Relationship Scale
BMI: Body Mass Index
DAD: Disabilities Assessment for Dementia
ZBI: Zarit Burden Interview short version
MDIS: Morycz Desire-to-Institutionalize Scale
CAQ: Caregiver Anxiety Measure
CDQ: Caregiver Depression Measure
SUVr: Standardized Uptake Value Ratio
MMSE: Mini-Mental State Examination
T2 MRI: T2-weighted Magnetic Resonance Imaging
SWI MRI: Susceptibility-Weighted Imaging Magnetic Resonance Imaging
BBB Opening Volume: Blood-Brain Barrier Opening Volume (mm³)
ARIA-edema: Number of participants diagnosed with ARIA edema
ARIA-hemorrhage: Number of participants diagnosed with ARIA hemorrhage or superficial siderosis
Serum ADA: Presence of anti‑drug antibodies detected by a validated assay
TMAX: Time to Peak Concentration
HALF‑LIFE: Drug Elimination Half‑Life
CLss/F: Apparent Clearance at Steady State Under Fasting
Cmax: Peak Plasma Concentration
Vzss/F: Apparent Volume of Distribution at Steady State Under Fasting
AUC0-24: Area Under Curve 0‑24 Hours
AUC0-12: Area Under Curve 0‑12 Hours
CTRROUGHS: Trough Concentration
SBP CHANGE: Mean Change From Baseline In Systolic Blood Pressure
DBP CHANGE: Mean Change From Baseline In Diastolic Blood Pressure
HR CHANGE: Mean Change From Baseline In Heart Rate
AE URINALYSIS: Number Of Participants With Abnormal Urinalysis Results
AE HEMATOLOGY: Number Of Participants With Abnormal Hematology‑Related AEs
AE CHEMISTRY: Number Of Participants With Abnormal Chemistry‑Related AEs
NEURO EXAM: Number Of Participants With Abnormal (Impaired) Targeted Neurological Exam Results
C-SSRS: Columbia Suicide Severity Rating Scale
ZBI: 22-item Zarit Burden Inventory
RMBPC: Revised Memory and Behavior Problem Checklist
PSS: 14-item Perceived Stress Scale
AE: Adverse Event Count
SAE: Serious Adverse Event Count
C-SSRS: Columbia Suicide Severity Rating Scale
ARIA-H: Hemorrhagic ARIA (cerebral microbleeds/leptomeningeal hemosiderosis) detected on MRI
ARIA-E: Edema or effusion detected on MRI
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADA: Anti‑Drug Antibody against gantenerumab
DSST: Digit Symbol Substitution Test
VFT: Verbal Fluency Test
ADAS-Cog13: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 13
DWR: Delayed Word Recall
NC: Number Cancellation
C-SSRS: Columbia Suicide Severity Rating Scale
ADAS-Cog11: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 11
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
FAQ: Functional Activities Questionnaire
MMSE: Mini‑Mental State Examination
AE: Adverse Event
SAE: Serious Adverse Event
SLUMS: Saint Louis University Mental Status
ADAS-Cog 11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11-item
CSF Tau: Cerebrospinal Fluid Tau protein concentration
CSF GFAP: Cerebrospinal Fluid Glial Fibrillary Acidic Protein concentration
CSF NfL: Cerebrospinal Fluid Neurofilament Light Chain protein concentration
CSF TREM2: Cerebrospinal Fluid Triggering Receptor Expressed on Myeloid Cells 2 concentration
CSF Neurogranin: Cerebrospinal Fluid Neurogranin concentration
TEAE: Treatment Emergent Adverse Events
MIRD: Medical Internal Radiation Dose
ICRP: International Commission on Radiological Protection
%ID: Percent Injected Dose
RT: Residence Time
KV: Kinetic Values
AUC: Area Under the Curve
ID: Injected Dose
AE: Adverse Event
SAE: Serious Adverse Event
TEAE: Treatment‑Emergent Adverse Event
AE: Adverse Event
SAE: Serious Adverse Event
TEAE: Treatment‑Emergent Adverse Event
Flortaucipir SUVr: Standard Uptake Value Ratio of flortaucipir PET
DSST: Digit Symbol Substitution Test
ADAS-Cog: Modified Alzheimer’s Disease Assessment Scale Cognitive Subscale
MMSE: Mini‑Mental State Examination
Radiation Dose Estimate: Millisieverts per Megabecquerel (mSv/MBq)
ADCS-ADL23: Alzheimer's Disease Cooperative Study Activities of Daily Living 23‑item version
GST: Global Statistical Test
NfL: Neurofilament Light Chain
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
PSS: Perceived Stress Scale
DBS: Disturbing Behavior Scale
CES-D: Center for Epidemiological Studies Depression Scale
ERP-P300: Event‑Related Potential P300 Latency
ADAS-Cog11: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 11
DBS: Disturbing Behaviors Scale
PSS: Perceived Stress Scale
CES-D: Center for Epidemiologic Studies Depression Scale
SIB: Severe Impairment Battery
MMSE-2: Mini-Mental State Examination 2
TEAE: Treatment Emergent Adverse Event
SAE: Serious Adverse Event
NPI-Q: Neuropsychiatric Inventory Questionnaire
COPM: Canadian Occupational Performance Measure
AR: Adherence Rate
fMRI-CR: Percent of subjects who complete the fMRI protocol
INF-CR: Percent of subjects whose images were uploaded and analyzed by the Infinitome program
AE: Adverse Event
SAE: Serious Adverse Event
ADA: Antidrug Antibody
Centiloid: Centiloid scale for amyloid deposition
C-SSRS: Columbia Suicide Severity Rating Scale
ARIA-H: Amyloid Related Imaging Abnormality – Hemorrhagic
ARIA-E: Amyloid Related Imaging Abnormality – Edema
HAQ: Health Assessment Questionnaire
Amyloid PET SUVR: Standardized Uptake Value Ratio of amyloid PET
Amyloid PET Centiloid: Centiloid conversion of amyloid PET SUVR
LSNS: Lubben Social Network Scale
Global Health Scale: Global Health Scale
Social Isolation Measure: Three‑Item Social Isolation Scale
CT1812 Plasma Concentration: Pre‑dose and Post‑dose plasma levels of CT1812
MedDRA AE Coding: Adverse events coded using MedDRA Version 22.0
GRTP: Global Relative Theta Power measured by EEG
Vital Signs: Vital Signs measurement
Physical Exam: Physical Examination
Electrocardiogram: Electrocardiogram
Neuropsychiatric Inventory-Q: Neuropsychiatric Inventory Questionnaire
Geriatric Depression Scale: Geriatric Depression Scale
Glasgow Coma Scale: Glasgow Coma Scale
Montreal Cognitive Assessment: Montreal Cognitive Assessment
Lab Abnormalities: Count of participants with clinical lab abnormalities
Adverse Events: Count of participants experiencing adverse events
AUC: Area Under Curve (plasma drug exposure)
Cmax: Maximum Concentration (time of peak)
Max Plasma Concentration: Peak plasma concentration
mGluR5 Occupancy: Metabotropic Glutamate Receptor Subtype 5 Occupancy
IC50: Concentration producing 50% of maximal receptor occupancy
IC80: Concentration producing 80% of maximal receptor occupancy
PDAYS: Cumulative total of new antipsychotic prescription days supplied per eligible patient
IDEA: Number of patients receiving the non‑pharmacologic IDEA Strategy handout
E2814: Concentration of the investigational drug E2814
Anti-E2814: Anti‑E2814 Antibody titer
MTBR‑Tau: Total bound plus free MTBR‑tagged tau in CSF
Tau‑PET SUVR: Standardized Uptake Value Ratio of tau PET tracer
ZBI: Zarit Burden Interview
NPI: Neuropsychiatric Inventory
iADRS: Informant Alzheimer’s Disease Rating Scale
MMSE: Mini‑Mental State Examination
ADCS‑ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
CDR‑SB: Clinical Dementia Rating Scale Sum of Boxes
ADAS‑Cog12: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 12
P‑tau217: Phospho‑tau217
GFAP: Glial Fibrillary Acidic Protein
NfL: Neurofilament Light Chain
Tau: Total Tau
RR: Respiratory Rate
TEMP: Body Temperature
HR: Heart Rate
SBP: Systolic Blood Pressure
DBP: Diastolic Blood Pressure
PR: PR Interval
QRS: QRS Duration
QT: QT Interval
QTcB: QT Corrected Using Bazett's Formula
C-SSRS: Columbia Suicide Severity Rating Scale
MMSE: Mini‑Mental State Examination
NPI: Neuropsychiatric Inventory
CDR-SOB: Clinical Dementia Rating Scale Sum of Boxes
ALB: Serum Albumin
TP: Total Serum Protein
HB: Hemoglobin
HCT: Hematocrit
MCV: Mean Corpuscular Volume
MCH: Mean Corpuscular Hemoglobin
RET: Reticulocyte Count
WBC: White Blood Cell Count
NEUT: Neutrophil Count
LYMPH: Lymphocyte Count
MONO: Monocyte Count
EOS: Eosinophil Count
BASE: Basophil Count
PLT: Platelet Count
K+: Potassium
NA+: Sodium
CA2+: Calcium
CHO: Total Cholesterol
HDL: High‑Density Lipoprotein
LDL: Low‑Density Lipoprotein
TG: Triglycerides
CREA: Serum Creatinine
GLU: Blood Glucose
BD: Direct Bilirubin
TB: Total Bilirubin
UN: Urea Nitrogen
ALT: Alanine Aminotransferase
AST: Aspartate Aminotransferase
ALP: Alkaline Phosphatase
CK: Creatine Kinase
TSH: Thyroid Stimulating Hormone
HbA1c: Hemoglobin A1c
AB_TB006: Anti‑TB006 Antibody Titer
USG: Urine Specific Gravity
UPH: Urine pH
UROB: Urine Urobilinogen
AUCtau: Normalized Area Under Curve over dosing interval
Cmax: Normalized Maximum Observed Plasma Concentration
CT1812 Plasma Concentration: Area Under Curve of Plasma CT1812
CT1812 Total Radioactivity Concentration: Area Under Curve of Total Radioactivity
Urinary Cum%Dose: Cumulative Radioactive Dose Excreted in Urine
Fecal Cum%Dose: Cumulative Radioactive Dose Excreted in Feces
Whole Blood Total Radioactivity Concentration: Area Under Curve of Whole Blood Total Radioactivity
TRA % WB/PL: Percentage of Tracer Activity in Whole Blood Relative to Plasma
Fraction 14C-WB/PL/RBC: Distribution of 14C-Radioactivity Among Whole Blood Components
AE MedDRA: Adverse Events coded by MedDRA
MMSE: Mini-Mental State Examination
ADAS-Cog: Alzheimer’s Disease Assessment Scale-Cognitive Subscale
MoCA: Montreal Cognitive Assessment
QDRS: Quick Dementia Rating Scale
CDR: Clinical Dementia Rating
CFIa: Cognitive Functional Index (modified)
ARIA-E: Amyloid Related Imaging Abnormality – Edema/Effusion
ARIA-H: Amyloid Related Imaging Abnormality – Hemorrhage/Hemosiderosis
AE: Adverse Event
SAE: Serious Adverse Event
AESI: Adverse Event of Special Interest
PACC-5: Preclinical Alzheimer Cognitive Composite-5
MMSE: Mini Mental State Examination
WMS LM: Wechsler Memory Scale Logical Memory I & II
FCSRT: Free & Cued Selective Reminding Test
WAIS-IV Coding: Wechsler Adult Intelligence Scale Fourth Edition Coding
CFT: Category Fluency Test
C-SSRS: Columbia Suicide Severity Rating Scale
CDR-GS: Clinical Dementia Rating Global Score
CDR: Clinical Dementia Rating
CDR-SB: Clinical Dementia Rating Sum of Boxes
A-IADL-Q-SV: A-IADL-Q Short Version
ADA: Anti-Drug Antibody
TGd Parcellation Abnormal Connections: Count of abnormal connections in the TGd parcellation
SDI: Sleep Disturbance Index
NPI-12: Neuropsychiatric Inventory – 12 Domains
NPI-C: Neuropsychiatric Inventory – Clinician
CMAI-C: Cohen‑Mansfield Agitation Inventory – Clinician
GST: Global Summary Test z-score
CDR-SB: Clinical Dementia Rating Scale Sum of Boxes
ADASCog13: Alzheimer's Disease Assessment Scale Cognitive Subscale 13
ADCS-ADL-MCI: Alzheimer's Disease Cooperative Study Activities of Daily Living – Mild Cognitive Impairment
NPI-10: Neuropsychiatric Inventory – 10 items
Centiloid: Centiloid measurement of amyloid PET
SUVR: Standardized Uptake Value Ratio
MMSE: Mini-Mental State Examination
iADRS: Integrated Alzheimer’s Disease Rating Scale
CDR: Clinical Dementia Rating Scale
Perceived Stress: Perceived Stress Measurement
Depression Level: Depression Level Measurement
Caregiving Burden: Caregiver Burden Measurement
Caregiving Mastery: Caregiver Mastery Measurement
Positive Aspects to Caregiving: Positive Aspects to Caregiving Measurement
Positive Emotions: Positive Emotions Measurement
Life Purpose: Hopefulness, Optimism, Goal-Directedness Measurement
Sleep Disturbance: Sleep Disturbance Measurement
Social Isolation: Social Isolation Perception Measurement
Acceptability: Acceptability of SAGE-LEAF Measurement
Overload: Caregiver Overload Measurement
Anxiety Level: Anxiety Level Measurement
Time Burden: Caregiver Time Burden Measurement
Usability: Usability of SAGE-LEAF Measurement
Role Captivity: Role Captivity Measurement
SAGE-LEAF Adherence: SAGE-LEAF Intervention Adherence Score
ADAS-Cog11: Alzheimer’s Disease Assessment Scale – Cognitive Subscale 11
ADCS-CGIC: Alzheimer’s Disease Cooperative Study Clinical Global Impression of Change
ADCS-ADL: Alzheimer’s Disease Cooperative Study Activities of Daily Living
ADCS-CGIC: Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change
ADAS-Cog11: Alzheimer's Disease Assessment Scale-Cognitive Subscale 11
ADCS-ADL: Alzheimer's Disease Cooperative Study-Instrumental Activities of Daily Living Scale
GFAP: Glial Fibrillary Acidic Protein
NFL: Neurofilament Light
TDP43: TAR DNA-binding Protein 43
